{
"version": "2.2",
"instance": {
"xenetic_i10k-123123.htm": {
"nsprefix": "xbio",
"nsuri": "http://xeneticbio.com/20231231",
"dts": {
"schema": {
"local": [
"xbio-20231231.xsd"
],
"remote": [
"http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
"http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
"http://www.xbrl.org/2003/xl-2003-12-31.xsd",
"http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
"http://www.xbrl.org/2005/xbrldt-2005.xsd",
"http://www.xbrl.org/2006/ref-2006-02-27.xsd",
"http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
"http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
"https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
"https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
"https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
"https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
"https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
"https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
"https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
"https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
"https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
"https://xbrl.sec.gov/country/2023/country-2023.xsd",
"https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
"https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
]
},
"calculationLink": {
"local": [
"xbio-20231231_cal.xml"
]
},
"definitionLink": {
"local": [
"xbio-20231231_def.xml"
]
},
"labelLink": {
"local": [
"xbio-20231231_lab.xml"
]
},
"presentationLink": {
"local": [
"xbio-20231231_pre.xml"
]
},
"inline": {
"local": [
"xenetic_i10k-123123.htm"
]
}
},
"keyStandard": 248,
"keyCustom": 25,
"axisStandard": 20,
"axisCustom": 0,
"memberStandard": 21,
"memberCustom": 31,
"hidden": {
"total": 46,
"http://xeneticbio.com/20231231": 20,
"http://fasb.org/us-gaap/2023": 22,
"http://xbrl.sec.gov/dei/2023": 4
},
"contextCount": 160,
"entityCount": 1,
"segmentCount": 60,
"elementCount": 527,
"unitCount": 4,
"baseTaxonomies": {
"http://fasb.org/us-gaap/2023": 509,
"http://xbrl.sec.gov/dei/2023": 41,
"http://xbrl.sec.gov/ecd/2023": 4
},
"report": {
"R1": {
"role": "http://xeneticbio.com/role/Cover",
"longName": "00000001 - Document - Cover",
"shortName": "Cover",
"isDefault": "true",
"groupType": "document",
"subGroupType": "",
"menuCat": "Cover",
"order": "1",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "dei:DocumentType",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"b",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R2": {
"role": "http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS",
"shortName": "CONSOLIDATED BALANCE SHEETS",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "2",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:Cash",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:Cash",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R3": {
"role": "http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
"shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "parenthetical",
"menuCat": "Statements",
"order": "3",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:PreferredStockSharesAuthorized",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:PreferredStockSharesAuthorized",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R4": {
"role": "http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss",
"longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
"shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "4",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:RoyaltyIncomeNonoperating",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:Revenues",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R5": {
"role": "http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLossParenthetical",
"longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
"shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "parenthetical",
"menuCat": "Statements",
"order": "5",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:EarningsPerShareBasic",
"unitRef": "USDPShares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:EarningsPerShareBasic",
"unitRef": "USDPShares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R6": {
"role": "http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
"shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "6",
"firstAnchor": {
"contextRef": "AsOf2021-12-31_us-gaap_PreferredStockMember",
"name": "us-gaap:StockholdersEquity",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2021-12-31_us-gaap_PreferredStockMember",
"name": "us-gaap:StockholdersEquity",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R7": {
"role": "http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows",
"longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
"shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
"isDefault": "false",
"groupType": "statement",
"subGroupType": "",
"menuCat": "Statements",
"order": "7",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:NetIncomeLoss",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:ResearchAndDevelopmentsInProcess",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R8": {
"role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
"longName": "995410 - Disclosure - Pay vs Performance Disclosure",
"shortName": "Pay vs Performance Disclosure",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "8",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:NetIncomeLoss",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": null
},
"R9": {
"role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
"longName": "995445 - Disclosure - Insider Trading Arrangements",
"shortName": "Insider Trading Arrangements",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "9",
"firstAnchor": {
"contextRef": "From2023-10-012023-12-31",
"name": "ecd:Rule10b51ArrAdoptedFlag",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-10-012023-12-31",
"name": "ecd:Rule10b51ArrAdoptedFlag",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"span",
"p",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R10": {
"role": "http://xeneticbio.com/role/Company",
"longName": "995513 - Disclosure - The Company",
"shortName": "The Company",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "10",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:TheCompanyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:TheCompanyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R11": {
"role": "http://xeneticbio.com/role/RisksAndUncertainties",
"longName": "995514 - Disclosure - Risks and Uncertainties",
"shortName": "Risks and Uncertainties",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "11",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R12": {
"role": "http://xeneticbio.com/role/SummaryOfSignificantAccountingPolicies",
"longName": "995515 - Disclosure - Summary of Significant Accounting Policies",
"shortName": "Summary of Significant Accounting Policies",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "12",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:SignificantAccountingPoliciesTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R13": {
"role": "http://xeneticbio.com/role/SignificantStrategicCollaborations",
"longName": "995516 - Disclosure - Significant Strategic Collaborations",
"shortName": "Significant Strategic Collaborations",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "13",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R14": {
"role": "http://xeneticbio.com/role/LicensingArrangements",
"longName": "995517 - Disclosure - Licensing Arrangements",
"shortName": "Licensing Arrangements",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "14",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:LicensingArrangementsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:LicensingArrangementsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R15": {
"role": "http://xeneticbio.com/role/OtherAssets",
"longName": "995518 - Disclosure - Other Assets",
"shortName": "Other Assets",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "15",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:OtherAssetsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:OtherAssetsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R16": {
"role": "http://xeneticbio.com/role/AccruedExpenses",
"longName": "995519 - Disclosure - Accrued Expenses",
"shortName": "Accrued Expenses",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "16",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R17": {
"role": "http://xeneticbio.com/role/FairValueMeasurements",
"longName": "995520 - Disclosure - Fair Value Measurements",
"shortName": "Fair Value Measurements",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "17",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:FairValueDisclosuresTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R18": {
"role": "http://xeneticbio.com/role/IncomeTaxes",
"longName": "995521 - Disclosure - Income Taxes",
"shortName": "Income Taxes",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "18",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:IncomeTaxDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R19": {
"role": "http://xeneticbio.com/role/StockholdersEquity",
"longName": "995522 - Disclosure - Stockholders\u2019 Equity",
"shortName": "Stockholders\u2019 Equity",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "19",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R20": {
"role": "http://xeneticbio.com/role/Share-basedExpense",
"longName": "995523 - Disclosure - Share-Based Expense",
"shortName": "Share-Based Expense",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "20",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R21": {
"role": "http://xeneticbio.com/role/EmployeeBenefitPlans",
"longName": "995524 - Disclosure - Employee Benefit Plans",
"shortName": "Employee Benefit Plans",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "21",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R22": {
"role": "http://xeneticbio.com/role/CommitmentsAndContingencies",
"longName": "995525 - Disclosure - Commitments and Contingencies",
"shortName": "Commitments and Contingencies",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "22",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CommitmentsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CommitmentsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R23": {
"role": "http://xeneticbio.com/role/RelatedPartyTransactions",
"longName": "995526 - Disclosure - Related Party Transactions",
"shortName": "Related Party Transactions",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "23",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R24": {
"role": "http://xeneticbio.com/role/SubsequentEvents",
"longName": "995527 - Disclosure - Subsequent Events",
"shortName": "Subsequent Events",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "",
"menuCat": "Notes",
"order": "24",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:SubsequentEventsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:SubsequentEventsTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R25": {
"role": "http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
"longName": "995528 - Disclosure - Summary of Significant Accounting Policies (Policies)",
"shortName": "Summary of Significant Accounting Policies (Policies)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "policies",
"menuCat": "Policies",
"order": "25",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:PreparationOfInterimFinancialStatementsPolicyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:PreparationOfInterimFinancialStatementsPolicyTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R26": {
"role": "http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesTables",
"longName": "995529 - Disclosure - Summary of Significant Accounting Policies (Tables)",
"shortName": "Summary of Significant Accounting Policies (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "26",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:AssetsEstimatedUsefulLifeTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "xbio:AssetsEstimatedUsefulLifeTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R27": {
"role": "http://xeneticbio.com/role/AccruedExpensesTables",
"longName": "995530 - Disclosure - Accrued Expenses (Tables)",
"shortName": "Accrued Expenses (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "27",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R28": {
"role": "http://xeneticbio.com/role/IncomeTaxesTables",
"longName": "995531 - Disclosure - Income Taxes (Tables)",
"shortName": "Income Taxes (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "28",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R29": {
"role": "http://xeneticbio.com/role/Share-basedExpenseTables",
"longName": "995532 - Disclosure - Share-Based Expense (Tables)",
"shortName": "Share-Based Expense (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "29",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R30": {
"role": "http://xeneticbio.com/role/CommitmentsAndContingenciesTables",
"longName": "995533 - Disclosure - Commitments and Contingencies (Tables)",
"shortName": "Commitments and Contingencies (Tables)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "tables",
"menuCat": "Tables",
"order": "30",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CashFlowOperatingCapitalTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CashFlowOperatingCapitalTableTextBlock",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R31": {
"role": "http://xeneticbio.com/role/CompanyDetailsNarrative",
"longName": "995534 - Disclosure - The Company (Details Narrative)",
"shortName": "The Company (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "31",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:CommonStockParOrStatedValuePerShare",
"unitRef": "USDPShares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-05-142023-05-15_us-gaap_CommonStockMember",
"name": "us-gaap:StockholdersEquityNoteStockSplit",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"p",
"xbio:TheCompanyTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R32": {
"role": "http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails",
"longName": "995535 - Disclosure - Summary of Significant Accounting Policies (Details)",
"shortName": "Summary of Significant Accounting Policies (Details)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "32",
"firstAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_OfficeAndComputerEquipmentMember",
"name": "xbio:PropertyPlantAndEquipmentEstimatedUsefulLives1",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"xbio:AssetsEstimatedUsefulLifeTableTextBlock",
"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_OfficeAndComputerEquipmentMember",
"name": "xbio:PropertyPlantAndEquipmentEstimatedUsefulLives1",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"xbio:AssetsEstimatedUsefulLifeTableTextBlock",
"us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R33": {
"role": "http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
"longName": "995536 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
"shortName": "Summary of Significant Accounting Policies (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "33",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AssetImpairmentCharges",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AssetImpairmentCharges",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"us-gaap:SignificantAccountingPoliciesTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R34": {
"role": "http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"longName": "995537 - Disclosure - Significant Strategic Collaborations (Details Narrative)",
"shortName": "Significant Strategic Collaborations (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "34",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:RoyaltyIncomeNonoperating",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-03-162023-03-17",
"name": "us-gaap:OtherResearchAndDevelopmentExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:CollaborativeArrangementDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R35": {
"role": "http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"longName": "995538 - Disclosure - Licensing Arrangements (Details Narrative)",
"shortName": "Licensing Arrangements (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "35",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ResearchAndDevelopmentExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31_custom_CLSMember",
"name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
"unitRef": "Pure",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"p",
"xbio:LicensingArrangementsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R36": {
"role": "http://xeneticbio.com/role/OtherAssetsDetailsNarrative",
"longName": "995539 - Disclosure - Other Assets (Details Narrative)",
"shortName": "Other Assets (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "36",
"firstAnchor": {
"contextRef": "AsOf2023-12-31_custom_SerumInstituteMember",
"name": "us-gaap:PrepaidExpenseNoncurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:OtherAssetsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31_custom_SerumInstituteMember",
"name": "us-gaap:PrepaidExpenseNoncurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:OtherAssetsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R37": {
"role": "http://xeneticbio.com/role/AccruedExpensesDetails",
"longName": "995540 - Disclosure - Accrued Expenses (Details)",
"shortName": "Accrued Expenses (Details)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "37",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
"us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
"us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R38": {
"role": "http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative",
"longName": "995541 - Disclosure - Fair Value Measurements (Details Narrative)",
"shortName": "Fair Value Measurements (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "38",
"firstAnchor": {
"contextRef": "AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member",
"name": "us-gaap:FinancialInstrumentsOwnedAtFairValue",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:FairValueDisclosuresTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31_us-gaap_FairValueInputsLevel3Member",
"name": "us-gaap:FinancialInstrumentsOwnedAtFairValue",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:FairValueDisclosuresTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R39": {
"role": "http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"longName": "995542 - Disclosure - Income Taxes (Details - Income by geographic regions)",
"shortName": "Income Taxes (Details - Income by geographic regions)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "39",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:NetIncomeLoss",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_country_US",
"name": "us-gaap:NetIncomeLoss",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R40": {
"role": "http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation",
"longName": "995543 - Disclosure - Income Taxes (Details - Tax reconciliation)",
"shortName": "Income Taxes (Details - Tax reconciliation)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "40",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CurrentFederalTaxExpenseBenefit",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:CurrentFederalTaxExpenseBenefit",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R41": {
"role": "http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"longName": "995544 - Disclosure - Income Taxes (Details - Deferred Tax Assets)",
"shortName": "Income Taxes (Details - Deferred Tax Assets)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "41",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R42": {
"role": "http://xeneticbio.com/role/IncomeTaxesDetailsNarrative",
"longName": "995545 - Disclosure - Income Taxes (Details Narrative)",
"shortName": "Income Taxes (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "42",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:LiabilityForUncertainTaxPositionsCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:LiabilityForUncertainTaxPositionsCurrent",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"span",
"p",
"us-gaap:IncomeTaxDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R43": {
"role": "http://xeneticbio.com/role/StockholdersEquityDetailsNarrative",
"longName": "995546 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
"shortName": "Stockholders\u2019 Equity (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "43",
"firstAnchor": {
"contextRef": "AsOf2023-12-31",
"name": "us-gaap:CommonStockSharesAuthorized",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "AsOf2022-12-21",
"name": "us-gaap:CommonStockSharesAuthorized",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"p",
"us-gaap:StockholdersEquityNoteDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R44": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense",
"longName": "995547 - Disclosure - Share-Based Expense (Details - Share based expense)",
"shortName": "Share-Based Expense (Details - Share based expense)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "44",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ShareBasedCompensation",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:ShareBasedCompensation",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R45": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"longName": "995548 - Disclosure - Share-Based Expense (Details - Assumptions Employee)",
"shortName": "Share-Based Expense (Details - Assumptions Employee)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "45",
"firstAnchor": {
"contextRef": "From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
"unitRef": "Pure",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
"unitRef": "Pure",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R46": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"longName": "995549 - Disclosure - Share-Based Expense (Details - Employee option activity)",
"shortName": "Share-Based Expense (Details - Employee option activity)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "46",
"firstAnchor": {
"contextRef": "AsOf2022-12-31_us-gaap_EmployeeStockOptionMember",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_us-gaap_EmployeeStockOptionMember",
"name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R47": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"longName": "995550 - Disclosure - Share-Based Expense (Details - Non-Vested employee Option activity)",
"shortName": "Share-Based Expense (Details - Non-Vested employee Option activity)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "47",
"firstAnchor": {
"contextRef": "AsOf2022-12-31_custom_NonVestedEmployeeStockOptionMember",
"name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "AsOf2022-12-31_custom_NonVestedEmployeeStockOptionMember",
"name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R48": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"longName": "995551 - Disclosure - Share-Based Expense (Details - Non-employee option activity)",
"shortName": "Share-Based Expense (Details - Non-employee option activity)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "48",
"firstAnchor": {
"contextRef": "AsOf2022-12-31_custom_NonEmployeeStockOptionsMember",
"name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"unitRef": "Shares",
"xsiNil": "false",
"lang": null,
"decimals": "INF",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_NonEmployeeStockOptionsMember",
"name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"td",
"tr",
"table",
"us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"unique": true
}
},
"R49": {
"role": "http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"longName": "995552 - Disclosure - Share-Based Expense (Details Narrative)",
"shortName": "Share-Based Expense (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "49",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:AllocatedShareBasedCompensationExpense",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R50": {
"role": "http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative",
"longName": "995553 - Disclosure - Employee Benefit Plans (Details Narrative)",
"shortName": "Employee Benefit Plans (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "50",
"firstAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_Plan401KMember",
"name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_Plan401KMember",
"name": "us-gaap:DefinedBenefitPlanContributionsByEmployer",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R51": {
"role": "http://xeneticbio.com/role/CommitmentsAndContingenciesDetails-CashFlowInformation",
"longName": "995554 - Disclosure - Commitments and Contingencies (Details - Cash flow Information)",
"shortName": "Commitments and Contingencies (Details - Cash flow Information)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "51",
"firstAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:OperatingLeasePayments",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:CashFlowOperatingCapitalTableTextBlock",
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-01to2023-12-31",
"name": "us-gaap:OperatingLeasePayments",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"td",
"tr",
"table",
"us-gaap:CashFlowOperatingCapitalTableTextBlock",
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R52": {
"role": "http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative",
"longName": "995555 - Disclosure - Commitments and Contingencies (Details Narrative)",
"shortName": "Commitments and Contingencies (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "52",
"firstAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_CorporateHeadquartersMember",
"name": "us-gaap:LesseeOperatingLeaseDescription",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"p",
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_CorporateHeadquartersMember",
"name": "us-gaap:LesseeOperatingLeaseDescription",
"unitRef": null,
"xsiNil": "false",
"lang": "en-US",
"decimals": null,
"ancestors": [
"span",
"p",
"us-gaap:CommitmentsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
},
"R53": {
"role": "http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative",
"longName": "995556 - Disclosure - Related Party Transactions (Details Narrative)",
"shortName": "Related Party Transactions (Details Narrative)",
"isDefault": "false",
"groupType": "disclosure",
"subGroupType": "details",
"menuCat": "Details",
"order": "53",
"firstAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_CoDevelopmentAgreementMember",
"name": "us-gaap:InterestAndFeeIncomeOtherLoans",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
},
"uniqueAnchor": {
"contextRef": "From2023-01-012023-12-31_custom_CoDevelopmentAgreementMember",
"name": "us-gaap:InterestAndFeeIncomeOtherLoans",
"unitRef": "USD",
"xsiNil": "false",
"lang": null,
"decimals": "0",
"ancestors": [
"span",
"p",
"us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
"body",
"html"
],
"reportCount": 1,
"baseRef": "xenetic_i10k-123123.htm",
"first": true,
"unique": true
}
}
},
"tag": {
"xbio_ATMAgreementMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ATMAgreementMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Purchase Warrants",
"label": "Purchase Warrants [Default Label]"
}
}
},
"auth_ref": [
]
},
"us-gaap_AccountingPoliciesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccountingPoliciesAbstract",
"lang": {
"en-us": {
"role": {
"label": "Accounting Policies [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued expenses",
"documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
}
}
},
"auth_ref": [
"r21"
]
},
"us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/AccruedExpenses"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued Expenses",
"documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
}
}
},
"auth_ref": [
"r20"
]
},
"us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued expenses and other current liabilities",
"documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
}
}
},
"auth_ref": [
]
},
"us-gaap_AccountsPayableCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccountsPayableCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_LiabilitiesCurrent",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Accounts payable",
"documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r19",
"r560"
]
},
"us-gaap_AccruedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccruedLiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/AccruedExpensesDetails": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesDetails"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total accrued expenses",
"label": "Accrued Liabilities, Current",
"documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r23"
]
},
"us-gaap_AccruedProfessionalFeesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccruedProfessionalFeesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/AccruedExpensesDetails": {
"parentTag": "us-gaap_AccruedLiabilitiesCurrent",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued professional fees",
"documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r23"
]
},
"xbio_AccruedResearchCosts": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "AccruedResearchCosts",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/AccruedExpensesDetails": {
"parentTag": "us-gaap_AccruedLiabilitiesCurrent",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued research costs",
"documentation": "Accrued research costs"
}
}
},
"auth_ref": [
]
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r148",
"r149",
"r361",
"r362",
"r363",
"r364",
"r365",
"r366"
]
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 5.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Accumulated other comprehensive income",
"documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
}
}
},
"auth_ref": [
"r29",
"r30",
"r81",
"r143",
"r407",
"r424",
"r425"
]
},
"us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccumulatedOtherComprehensiveIncomeLossTable",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Accumulated Other Comprehensive Income (Loss) [Table]",
"documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)."
}
}
},
"auth_ref": [
"r148",
"r149",
"r361",
"r362",
"r363",
"r364",
"r365",
"r366"
]
},
"us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AccumulatedOtherComprehensiveIncomeMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "AOCI Attributable to Parent [Member]",
"documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
}
}
},
"auth_ref": [
"r2",
"r10",
"r30",
"r346",
"r349",
"r373",
"r420",
"r421",
"r678",
"r679",
"r680",
"r686",
"r687",
"r688"
]
},
"ecd_Additional402vDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "Additional402vDisclosureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Additional 402(v) Disclosure [Text Block]"
}
}
},
"auth_ref": [
"r624"
]
},
"us-gaap_AdditionalPaidInCapital": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AdditionalPaidInCapital",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Additional paid in capital",
"documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
}
}
},
"auth_ref": [
"r74",
"r560",
"r779"
]
},
"us-gaap_AdditionalPaidInCapitalMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AdditionalPaidInCapitalMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Additional Paid-in Capital [Member]",
"documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
}
}
},
"auth_ref": [
"r306",
"r307",
"r308",
"r437",
"r686",
"r687",
"r688",
"r769",
"r780"
]
},
"ecd_AdjToCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AdjToCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Compensation Amount"
}
}
},
"auth_ref": [
"r630"
]
},
"ecd_AdjToCompAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AdjToCompAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Compensation [Axis]"
}
}
},
"auth_ref": [
"r630"
]
},
"ecd_AdjToNonPeoNeoCompFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AdjToNonPeoNeoCompFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
}
}
},
"auth_ref": [
"r630"
]
},
"ecd_AdjToPeoCompFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AdjToPeoCompFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustment To PEO Compensation, Footnote [Text Block]"
}
}
},
"auth_ref": [
"r630"
]
},
"us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Share-based expense",
"documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r54",
"r55",
"r269"
]
},
"us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Adjustments to reconcile net loss to net cash used in operating activities:"
}
}
},
"auth_ref": [
]
},
"ecd_AggtErrCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AggtErrCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Erroneous Compensation Amount"
}
}
},
"auth_ref": [
"r594",
"r606",
"r616",
"r642"
]
},
"ecd_AggtErrCompNotYetDeterminedTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AggtErrCompNotYetDeterminedTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
}
}
},
"auth_ref": [
"r597",
"r609",
"r619",
"r645"
]
},
"ecd_AllAdjToCompMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AllAdjToCompMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"auth_ref": [
"r630"
]
},
"ecd_AllExecutiveCategoriesMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AllExecutiveCategoriesMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"auth_ref": [
"r637"
]
},
"ecd_AllIndividualsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AllIndividualsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"auth_ref": [
"r601",
"r610",
"r620",
"r637",
"r646",
"r650",
"r658"
]
},
"ecd_AllTradingArrangementsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AllTradingArrangementsMember",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"auth_ref": [
"r656"
]
},
"us-gaap_AllocatedShareBasedCompensationExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AllocatedShareBasedCompensationExpense",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Share-based compensation expense",
"documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
}
}
},
"auth_ref": [
"r301",
"r313"
]
},
"dei_AmendmentDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AmendmentDescription",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Description",
"documentation": "Description of changes contained within amended document."
}
}
},
"auth_ref": [
]
},
"dei_AmendmentFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AmendmentFlag",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Amendment Flag",
"documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
}
}
},
"auth_ref": [
]
},
"dei_AnnualInformationForm": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AnnualInformationForm",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Annual Information Form",
"documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
}
}
},
"auth_ref": [
"r602"
]
},
"us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Antidilutive shares",
"documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
}
}
},
"auth_ref": [
"r185"
]
},
"us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ArrangementsAndNonarrangementTransactionsMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
}
}
},
"auth_ref": [
"r340"
]
},
"us-gaap_AssetAcquisitionAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetAcquisitionAxis",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Asset Acquisition [Axis]",
"documentation": "Information by asset acquisition."
}
}
},
"auth_ref": [
"r765"
]
},
"us-gaap_AssetAcquisitionConsiderationTransferred": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetAcquisitionConsiderationTransferred",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Total consideration",
"documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
}
}
},
"auth_ref": [
"r559",
"r766",
"r767",
"r768"
]
},
"us-gaap_AssetAcquisitionDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetAcquisitionDomain",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Asset acquisition."
}
}
},
"auth_ref": [
"r765"
]
},
"us-gaap_AssetImpairmentCharges": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetImpairmentCharges",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Asset Impairment Charges",
"documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
}
}
},
"auth_ref": [
"r5",
"r42"
]
},
"us-gaap_Assets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "Assets",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total assets",
"label": "Assets",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
}
}
},
"auth_ref": [
"r112",
"r139",
"r160",
"r190",
"r202",
"r206",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r341",
"r343",
"r359",
"r402",
"r474",
"r560",
"r571",
"r694",
"r695",
"r774"
]
},
"us-gaap_AssetsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetsAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "ASSETS"
}
}
},
"auth_ref": [
]
},
"us-gaap_AssetsCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetsCurrent",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_Assets",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total current assets",
"label": "Assets, Current",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
}
}
},
"auth_ref": [
"r136",
"r144",
"r160",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r341",
"r343",
"r359",
"r560",
"r694",
"r695",
"r774"
]
},
"us-gaap_AssetsCurrentAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AssetsCurrentAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Current assets:"
}
}
},
"auth_ref": [
]
},
"xbio_AssetsEstimatedUsefulLifeTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "AssetsEstimatedUsefulLifeTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of estimated useful life of assets"
}
}
},
"auth_ref": [
]
},
"dei_AuditedAnnualFinancialStatements": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AuditedAnnualFinancialStatements",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Audited Annual Financial Statements",
"documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
}
}
},
"auth_ref": [
"r602"
]
},
"dei_AuditorFirmId": {
"xbrltype": "nonemptySequenceNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AuditorFirmId",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Firm ID",
"documentation": "PCAOB issued Audit Firm Identifier"
}
}
},
"auth_ref": [
"r587",
"r589",
"r602"
]
},
"dei_AuditorLocation": {
"xbrltype": "internationalNameItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AuditorLocation",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Location"
}
}
},
"auth_ref": [
"r587",
"r589",
"r602"
]
},
"dei_AuditorName": {
"xbrltype": "internationalNameItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "AuditorName",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Auditor Name"
}
}
},
"auth_ref": [
"r587",
"r589",
"r602"
]
},
"ecd_AwardExrcPrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardExrcPrice",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Exercise Price"
}
}
},
"auth_ref": [
"r653"
]
},
"ecd_AwardGrantDateFairValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardGrantDateFairValue",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Grant Date Fair Value"
}
}
},
"auth_ref": [
"r654"
]
},
"ecd_AwardTmgDiscLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgDiscLineItems",
"auth_ref": [
"r649"
]
},
"ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgHowMnpiCnsdrdTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing, How MNPI Considered [Text Block]"
}
}
},
"auth_ref": [
"r649"
]
},
"ecd_AwardTmgMethodTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgMethodTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing Method [Text Block]"
}
}
},
"auth_ref": [
"r649"
]
},
"ecd_AwardTmgMnpiCnsdrdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgMnpiCnsdrdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing MNPI Considered [Flag]"
}
}
},
"auth_ref": [
"r649"
]
},
"ecd_AwardTmgMnpiDiscTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgMnpiDiscTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing MNPI Disclosure [Text Block]"
}
}
},
"auth_ref": [
"r649"
]
},
"ecd_AwardTmgPredtrmndFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardTmgPredtrmndFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Timing Predetermined [Flag]"
}
}
},
"auth_ref": [
"r649"
]
},
"us-gaap_AwardTypeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "AwardTypeAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"http://xeneticbio.com/role/Share-basedExpenseTables",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Award Type [Axis]",
"documentation": "Information by type of award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r272",
"r273",
"r274",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r282",
"r283",
"r284",
"r285",
"r286",
"r287",
"r288",
"r289",
"r290",
"r291",
"r292",
"r293",
"r296",
"r297",
"r298",
"r299",
"r300"
]
},
"ecd_AwardUndrlygSecuritiesAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardUndrlygSecuritiesAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Award Underlying Securities Amount"
}
}
},
"auth_ref": [
"r652"
]
},
"ecd_AwardsCloseToMnpiDiscIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardsCloseToMnpiDiscIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures, Individual Name"
}
}
},
"auth_ref": [
"r651"
]
},
"ecd_AwardsCloseToMnpiDiscTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardsCloseToMnpiDiscTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures [Table]"
}
}
},
"auth_ref": [
"r650"
]
},
"ecd_AwardsCloseToMnpiDiscTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "AwardsCloseToMnpiDiscTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
}
}
},
"auth_ref": [
"r650"
]
},
"us-gaap_BalanceSheetLocationAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "BalanceSheetLocationAxis",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Balance Sheet Location [Axis]",
"documentation": "Information by location on balance sheet (statement of financial position)."
}
}
},
"auth_ref": [
]
},
"us-gaap_BalanceSheetLocationDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "BalanceSheetLocationDomain",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Location in the balance sheet (statement of financial position)."
}
}
},
"auth_ref": [
"r62",
"r63"
]
},
"us-gaap_BusinessCombinationsPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "BusinessCombinationsPolicy",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Acquisitions",
"documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
}
}
},
"auth_ref": [
"r60"
]
},
"country_CH": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/country/2023",
"localname": "CH",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "SWITZERLAND"
}
}
},
"auth_ref": [
]
},
"xbio_CLSMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CLSMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "CLS [Member]",
"documentation": "CLS [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_Cash": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "Cash",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Cash",
"documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
}
}
},
"auth_ref": [
"r121",
"r404",
"r448",
"r469",
"r560",
"r571",
"r672"
]
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Cash at beginning of period",
"periodEndLabel": "Cash at end of period",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
"documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
}
}
},
"auth_ref": [
"r33",
"r87",
"r157"
]
},
"us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net change in cash",
"label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
"documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
}
}
},
"auth_ref": [
"r1",
"r87"
]
},
"us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:"
}
}
},
"auth_ref": [
]
},
"us-gaap_CashFlowOperatingCapitalTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CashFlowOperatingCapitalTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Cash flow information regarding leases",
"documentation": "Tabular disclosure of the net increase (decrease) in operating capital in the operating section of the statement of cash flows, represents the entire footnote disclosure that provides details regarding the net change during the reporting period of all assets and liabilities used in operating activities."
}
}
},
"auth_ref": [
]
},
"xbio_CatalentPharmaSolutionsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CatalentPharmaSolutionsMember",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Catalent Pharma Solutions [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_ChangedPeerGroupFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ChangedPeerGroupFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Changed Peer Group, Footnote [Text Block]"
}
}
},
"auth_ref": [
"r628"
]
},
"dei_CityAreaCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "CityAreaCode",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "City Area Code",
"documentation": "Area code of city"
}
}
},
"auth_ref": [
]
},
"us-gaap_ClassOfStockDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ClassOfStockDomain",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/Cover",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
}
}
},
"auth_ref": [
"r133",
"r140",
"r141",
"r142",
"r160",
"r179",
"r180",
"r182",
"r184",
"r188",
"r189",
"r215",
"r220",
"r222",
"r223",
"r224",
"r227",
"r228",
"r233",
"r234",
"r237",
"r240",
"r246",
"r359",
"r428",
"r429",
"r430",
"r431",
"r437",
"r438",
"r439",
"r440",
"r441",
"r442",
"r443",
"r444",
"r445",
"r446",
"r447",
"r449",
"r461",
"r483",
"r505",
"r521",
"r522",
"r523",
"r524",
"r525",
"r667",
"r683",
"r689"
]
},
"us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Exercise price",
"documentation": "Exercise price per share or per unit of warrants or rights outstanding."
}
}
},
"auth_ref": [
"r247"
]
},
"us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants issued",
"documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
}
}
},
"auth_ref": [
"r247"
]
},
"us-gaap_ClassOfWarrantOrRightOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ClassOfWarrantOrRightOutstanding",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants outstanding",
"verboseLabel": "Purchase of outstanding warrants",
"documentation": "Number of warrants or rights outstanding."
}
}
},
"auth_ref": [
]
},
"xbio_CoDevelopmentAgreementMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CoDevelopmentAgreementMember",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Co Development Agreement [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_CoSelectedMeasureAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CoSelectedMeasureAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Company Selected Measure Amount"
}
}
},
"auth_ref": [
"r629"
]
},
"ecd_CoSelectedMeasureName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CoSelectedMeasureName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Company Selected Measure Name"
}
}
},
"auth_ref": [
"r629"
]
},
"us-gaap_CollaborativeArrangementDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CollaborativeArrangementDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborations"
],
"lang": {
"en-us": {
"role": {
"label": "Significant Strategic Collaborations",
"documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
}
}
},
"auth_ref": [
"r122",
"r124",
"r132"
]
},
"us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
"presentation": [
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r340"
]
},
"us-gaap_CommitmentsAndContingencies": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommitmentsAndContingencies",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Commitments and contingencies (Note 13)",
"documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
}
}
},
"auth_ref": [
"r25",
"r67",
"r403",
"r460"
]
},
"us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommitmentsAndContingenciesDisclosureAbstract",
"lang": {
"en-us": {
"role": {
"label": "Commitments and Contingencies Disclosure [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_CommitmentsDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommitmentsDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingencies"
],
"lang": {
"en-us": {
"role": {
"label": "Commitments and Contingencies",
"documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights."
}
}
},
"auth_ref": [
"r96"
]
},
"xbio_CommonStock0.001ParValuePerShareMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CommonStock0.001ParValuePerShareMember",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock, $0.001 par value per share"
}
}
},
"auth_ref": [
]
},
"xbio_CommonStockAwardsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CommonStockAwardsMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock Awards [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_CommonStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockMember",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common Stock [Member]",
"documentation": "Stock that is subordinate to all other stock of the issuer."
}
}
},
"auth_ref": [
"r562",
"r563",
"r564",
"r566",
"r567",
"r568",
"r569",
"r686",
"r687",
"r769",
"r778",
"r780"
]
},
"us-gaap_CommonStockParOrStatedValuePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockParOrStatedValuePerShare",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, par value",
"documentation": "Face amount or stated value per share of common stock."
}
}
},
"auth_ref": [
"r73"
]
},
"us-gaap_CommonStockSharesAuthorized": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockSharesAuthorized",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, shares authorized",
"documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
}
}
},
"auth_ref": [
"r73",
"r461"
]
},
"us-gaap_CommonStockSharesIssued": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockSharesIssued",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, shares, issued",
"documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
}
}
},
"auth_ref": [
"r73"
]
},
"us-gaap_CommonStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockSharesOutstanding",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, shares, outstanding",
"documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
}
}
},
"auth_ref": [
"r11",
"r73",
"r461",
"r480",
"r780",
"r781"
]
},
"us-gaap_CommonStockValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CommonStockValue",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock, $0.001 par value; 10,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 1,543,385 and 1,519,360 shares issued as of December 31, 2023 and December 31, 2022, respectively; 1,540,684 and 1,516,659 shares outstanding as of December 31, 2023 and December 31, 2022, respectively",
"documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
}
}
},
"auth_ref": [
"r73",
"r406",
"r560"
]
},
"ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
}
}
},
"auth_ref": [
"r634"
]
},
"ecd_CompActuallyPaidVsNetIncomeTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CompActuallyPaidVsNetIncomeTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Net Income [Text Block]"
}
}
},
"auth_ref": [
"r633"
]
},
"ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CompActuallyPaidVsOtherMeasureTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Other Measure [Text Block]"
}
}
},
"auth_ref": [
"r635"
]
},
"ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
}
}
},
"auth_ref": [
"r632"
]
},
"us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CompensationAndEmployeeBenefitPlansTextBlock",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlans"
],
"lang": {
"en-us": {
"role": {
"label": "Employee Benefit Plans",
"documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
}
}
},
"auth_ref": [
"r101",
"r102",
"r103",
"r104"
]
},
"us-gaap_CompensationAndRetirementDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CompensationAndRetirementDisclosureAbstract",
"lang": {
"en-us": {
"role": {
"label": "Retirement Benefits [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_ConcentrationRiskCreditRisk": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ConcentrationRiskCreditRisk",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Cash and Concentrations of Credit Risk",
"documentation": "Disclosure of accounting policy for credit risk."
}
}
},
"auth_ref": [
"r68",
"r126"
]
},
"us-gaap_ConcentrationRiskDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ConcentrationRiskDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/RisksAndUncertainties"
],
"lang": {
"en-us": {
"role": {
"label": "Risks and Uncertainties",
"documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
}
}
},
"auth_ref": [
"r91"
]
},
"us-gaap_ConsolidationPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ConsolidationPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Principles of Consolidation",
"documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
}
}
},
"auth_ref": [
"r61",
"r543"
]
},
"xbio_ConversionOfSeriesPreferredStockToCommonStock": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ConversionOfSeriesPreferredStockToCommonStock",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Conversion of Series A preferred stock to common stock"
}
}
},
"auth_ref": [
]
},
"xbio_ConversionOfSeriesPreferredStockToSharesOfCommonStock": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ConversionOfSeriesPreferredStockToSharesOfCommonStock",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Conversion of Series A preferred stock to shares of common stock"
}
}
},
"auth_ref": [
]
},
"xbio_ConversionOfSeriesPreferredStockToSharesOfCommonStockShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ConversionOfSeriesPreferredStockToSharesOfCommonStockShares",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Conversion of Series A preferred stock to shares of common stock, shares"
}
}
},
"auth_ref": [
]
},
"us-gaap_ConversionOfStockSharesConverted1": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ConversionOfStockSharesConverted1",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Stock converted, shares converted",
"documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
}
}
},
"auth_ref": [
"r34",
"r35",
"r36"
]
},
"xbio_ConvertibleCommonStockInEachYear": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ConvertibleCommonStockInEachYear",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Convertible common stock in each year"
}
}
},
"auth_ref": [
]
},
"xbio_CorporateHeadquartersMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "CorporateHeadquartersMember",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Corporate Headquarters [Member]"
}
}
},
"auth_ref": [
]
},
"srt_CounterpartyNameAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "CounterpartyNameAxis",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Counterparty Name [Axis]"
}
}
},
"auth_ref": [
"r162",
"r163",
"r229",
"r235",
"r379",
"r540",
"r542"
]
},
"dei_CountryRegion": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "CountryRegion",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Country Region",
"documentation": "Region code of country"
}
}
},
"auth_ref": [
]
},
"dei_CoverAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "CoverAbstract",
"lang": {
"en-us": {
"role": {
"documentation": "Cover page."
}
}
},
"auth_ref": [
]
},
"us-gaap_CurrentFederalTaxExpenseBenefit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CurrentFederalTaxExpenseBenefit",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Federal",
"documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
}
}
},
"auth_ref": [
"r671",
"r685",
"r764"
]
},
"dei_CurrentFiscalYearEndDate": {
"xbrltype": "gMonthDayItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "CurrentFiscalYearEndDate",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Current Fiscal Year End Date",
"documentation": "End date of current fiscal year in the format --MM-DD."
}
}
},
"auth_ref": [
]
},
"us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "CurrentStateAndLocalTaxExpenseBenefit",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "State",
"documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
}
}
},
"auth_ref": [
"r671",
"r685",
"r764"
]
},
"country_DE": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/country/2023",
"localname": "DE",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "GERMANY"
}
}
},
"auth_ref": [
]
},
"xbio_DNaseTechnologyMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "DNaseTechnologyMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "D Nase Technology [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
"lang": {
"en-us": {
"role": {
"label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_DeferredIncomeTaxLiabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredIncomeTaxLiabilities",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Total deferred tax liabilities",
"documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
}
}
},
"auth_ref": [
"r70",
"r71",
"r113",
"r327"
]
},
"us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsCapitalLossCarryforwards",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Foreign capital loss carryforwards",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsGross": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsGross",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Total deferred tax assets before valuation allowance",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
}
}
},
"auth_ref": [
"r328"
]
},
"us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "IPR&D",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsNet",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Net deferred tax assets",
"documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
}
}
},
"auth_ref": [
"r762"
]
},
"us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Foreign net operating loss carryforwards",
"label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Foreign net operating loss carryforwards",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "U.S. state net operating loss carryforwards",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsOther": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsOther",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Lease liability",
"documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsPropertyPlantAndEquipment",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Depreciation",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment."
}
}
},
"auth_ref": [
]
},
"us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Enhanced research and development tax credits",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
}
}
},
"auth_ref": [
"r58",
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Share-based expense",
"label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
"documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Capitalized research and experimental expenditure",
"documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DeferredTaxAssetsValuationAllowance": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxAssetsValuationAllowance",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Valuation allowance for deferred tax assets",
"label": "Deferred Tax Assets, Valuation Allowance",
"documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
}
}
},
"auth_ref": [
"r329"
]
},
"us-gaap_DeferredTaxLiabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxLiabilities",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Net deferred tax assets and liabilities",
"documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
}
}
},
"auth_ref": [
"r56",
"r762"
]
},
"us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DeferredTaxLiabilitiesLeasingArrangements",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Right of use asset - leases",
"documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
}
}
},
"auth_ref": [
"r59",
"r763"
]
},
"us-gaap_DefinedBenefitPlanContributionsByEmployer": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DefinedBenefitPlanContributionsByEmployer",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Contribution to defined contribution plan",
"documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets."
}
}
},
"auth_ref": [
"r249",
"r250",
"r257",
"r553",
"r554",
"r555",
"r556"
]
},
"us-gaap_DefinedBenefitPlanDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DefinedBenefitPlanDisclosureLineItems",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Defined Benefit Plan Disclosure [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
]
},
"xbio_DisclosureCompanyAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "DisclosureCompanyAbstract",
"lang": {
"en-us": {
"role": {
"label": "Company"
}
}
},
"auth_ref": [
]
},
"xbio_DisclosureLicensingArrangementsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "DisclosureLicensingArrangementsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Licensing Arrangements"
}
}
},
"auth_ref": [
]
},
"us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Share-Based Expense",
"documentation": "The entire disclosure for share-based payment arrangement."
}
}
},
"auth_ref": [
"r267",
"r271",
"r302",
"r303",
"r305",
"r558"
]
},
"us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Share-Based Payment Arrangement [Abstract]"
}
}
},
"auth_ref": [
]
},
"dei_DocumentAccountingStandard": {
"xbrltype": "accountingStandardItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentAccountingStandard",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Accounting Standard",
"documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
}
}
},
"auth_ref": [
"r589"
]
},
"dei_DocumentAnnualReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentAnnualReport",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Annual Report",
"documentation": "Boolean flag that is true only for a form used as an annual report."
}
}
},
"auth_ref": [
"r587",
"r589",
"r602"
]
},
"dei_DocumentFinStmtErrorCorrectionFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentFinStmtErrorCorrectionFlag",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Financial Statement Error Correction [Flag]",
"documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
}
}
},
"auth_ref": [
"r587",
"r589",
"r602",
"r638"
]
},
"dei_DocumentFiscalPeriodFocus": {
"xbrltype": "fiscalPeriodItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentFiscalPeriodFocus",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Period Focus",
"documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
}
}
},
"auth_ref": [
]
},
"dei_DocumentFiscalYearFocus": {
"xbrltype": "gYearItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentFiscalYearFocus",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Fiscal Year Focus",
"documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
}
}
},
"auth_ref": [
]
},
"dei_DocumentPeriodEndDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentPeriodEndDate",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period End Date",
"documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
}
}
},
"auth_ref": [
]
},
"dei_DocumentPeriodStartDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentPeriodStartDate",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Period Start Date",
"documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
}
}
},
"auth_ref": [
]
},
"dei_DocumentQuarterlyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentQuarterlyReport",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Quarterly Report",
"documentation": "Boolean flag that is true only for a form used as an quarterly report."
}
}
},
"auth_ref": [
"r588"
]
},
"dei_DocumentRegistrationStatement": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentRegistrationStatement",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Registration Statement",
"documentation": "Boolean flag that is true only for a form used as a registration statement."
}
}
},
"auth_ref": [
"r576"
]
},
"dei_DocumentShellCompanyEventDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentShellCompanyEventDate",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Event Date",
"documentation": "Date of event requiring a shell company report."
}
}
},
"auth_ref": [
"r589"
]
},
"dei_DocumentShellCompanyReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentShellCompanyReport",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Shell Company Report",
"documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
}
}
},
"auth_ref": [
"r589"
]
},
"dei_DocumentTransitionReport": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentTransitionReport",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Transition Report",
"documentation": "Boolean flag that is true only for a form used as a transition report."
}
}
},
"auth_ref": [
"r623"
]
},
"dei_DocumentType": {
"xbrltype": "submissionTypeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentType",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Document Type",
"documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
}
}
},
"auth_ref": [
]
},
"dei_DocumentsIncorporatedByReferenceTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "DocumentsIncorporatedByReferenceTextBlock",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Documents Incorporated by Reference [Text Block]",
"documentation": "Documents incorporated by reference."
}
}
},
"auth_ref": [
"r579"
]
},
"us-gaap_EarningsPerShareBasic": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EarningsPerShareBasic",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLossParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Basic net loss per share",
"documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
}
}
},
"auth_ref": [
"r152",
"r169",
"r170",
"r171",
"r172",
"r173",
"r177",
"r179",
"r182",
"r183",
"r184",
"r186",
"r353",
"r354",
"r399",
"r412",
"r545"
]
},
"us-gaap_EarningsPerShareDiluted": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EarningsPerShareDiluted",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLossParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Diluted net loss per share",
"documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
}
}
},
"auth_ref": [
"r152",
"r169",
"r170",
"r171",
"r172",
"r173",
"r179",
"r182",
"r183",
"r184",
"r186",
"r353",
"r354",
"r399",
"r412",
"r545"
]
},
"us-gaap_EarningsPerSharePolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EarningsPerSharePolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Basic and Diluted Net Loss per Share",
"documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
}
}
},
"auth_ref": [
"r37",
"r38"
]
},
"us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeBenefitsAndShareBasedCompensation",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Share-based expense",
"label": "Employee Benefits and Share-Based Compensation",
"documentation": "Amount of expense for employee benefit and equity-based compensation."
}
}
},
"auth_ref": [
]
},
"us-gaap_EmployeeRelatedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeRelatedLiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/AccruedExpensesDetails": {
"parentTag": "us-gaap_AccruedLiabilitiesCurrent",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued payroll and benefits",
"documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
}
}
},
"auth_ref": [
"r23"
]
},
"us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
]
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Unrecognized compensation expense",
"documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r304"
]
},
"us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Unrecognized compensation expense recognition period",
"documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
}
}
},
"auth_ref": [
"r304"
]
},
"us-gaap_EmployeeStockOptionMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EmployeeStockOptionMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Share-Based Payment Arrangement, Option [Member]",
"documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressAddressLine1": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressAddressLine1",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line One",
"documentation": "Address Line 1 such as Attn, Building Name, Street Name"
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressAddressLine2": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressAddressLine2",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Two",
"documentation": "Address Line 2 such as Street or Suite number"
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressAddressLine3": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressAddressLine3",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Address Line Three",
"documentation": "Address Line 3 such as an Office Park"
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressCityOrTown": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressCityOrTown",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, City or Town",
"documentation": "Name of the City or Town"
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressCountry": {
"xbrltype": "countryCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressCountry",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Country",
"documentation": "ISO 3166-1 alpha-2 country code."
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressPostalZipCode": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressPostalZipCode",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, Postal Zip Code",
"documentation": "Code for the postal or zip code"
}
}
},
"auth_ref": [
]
},
"dei_EntityAddressStateOrProvince": {
"xbrltype": "stateOrProvinceItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityAddressStateOrProvince",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Address, State or Province",
"documentation": "Name of the state or province."
}
}
},
"auth_ref": [
]
},
"dei_EntityBankruptcyProceedingsReportingCurrent": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityBankruptcyProceedingsReportingCurrent",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Bankruptcy Proceedings, Reporting Current",
"documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
}
}
},
"auth_ref": [
"r582"
]
},
"dei_EntityCentralIndexKey": {
"xbrltype": "centralIndexKeyItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityCentralIndexKey",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Central Index Key",
"documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityCommonStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityCommonStockSharesOutstanding",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Common Stock, Shares Outstanding",
"documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
}
}
},
"auth_ref": [
]
},
"dei_EntityCurrentReportingStatus": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityCurrentReportingStatus",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Current Reporting Status",
"documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": [
]
},
"dei_EntityDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityDomain",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
}
}
},
"auth_ref": [
]
},
"dei_EntityEmergingGrowthCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityEmergingGrowthCompany",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Emerging Growth Company",
"documentation": "Indicate if registrant meets the emerging growth company criteria."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityExTransitionPeriod": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityExTransitionPeriod",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Elected Not To Use the Extended Transition Period",
"documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
}
}
},
"auth_ref": [
"r666"
]
},
"dei_EntityFileNumber": {
"xbrltype": "fileNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityFileNumber",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity File Number",
"documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
}
}
},
"auth_ref": [
]
},
"dei_EntityFilerCategory": {
"xbrltype": "filerCategoryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityFilerCategory",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Filer Category",
"documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityIncorporationStateCountryCode": {
"xbrltype": "edgarStateCountryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityIncorporationStateCountryCode",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Incorporation, State or Country Code",
"documentation": "Two-character EDGAR code representing the state or country of incorporation."
}
}
},
"auth_ref": [
]
},
"dei_EntityInteractiveDataCurrent": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityInteractiveDataCurrent",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Interactive Data Current",
"documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
}
}
},
"auth_ref": [
"r663"
]
},
"dei_EntityPrimarySicNumber": {
"xbrltype": "sicNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityPrimarySicNumber",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Primary SIC Number",
"documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
}
}
},
"auth_ref": [
"r602"
]
},
"dei_EntityPublicFloat": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityPublicFloat",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Public Float",
"documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
}
}
},
"auth_ref": [
]
},
"dei_EntityRegistrantName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityRegistrantName",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Registrant Name",
"documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityShellCompany": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityShellCompany",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Shell Company",
"documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntitySmallBusiness": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntitySmallBusiness",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Small Business",
"documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityTaxIdentificationNumber": {
"xbrltype": "employerIdItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityTaxIdentificationNumber",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Tax Identification Number",
"documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
}
}
},
"auth_ref": [
"r578"
]
},
"dei_EntityVoluntaryFilers": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityVoluntaryFilers",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Voluntary Filers",
"documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
}
}
},
"auth_ref": [
]
},
"dei_EntityWellKnownSeasonedIssuer": {
"xbrltype": "yesNoItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "EntityWellKnownSeasonedIssuer",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Entity Well-known Seasoned Issuer",
"documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
}
}
},
"auth_ref": [
"r664"
]
},
"us-gaap_EquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EquityAbstract",
"lang": {
"en-us": {
"role": {
"label": "Equity [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_EquityComponentDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EquityComponentDomain",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
}
}
},
"auth_ref": [
"r11",
"r134",
"r148",
"r149",
"r150",
"r164",
"r165",
"r166",
"r168",
"r174",
"r176",
"r187",
"r216",
"r217",
"r248",
"r306",
"r307",
"r308",
"r333",
"r334",
"r345",
"r346",
"r347",
"r348",
"r349",
"r350",
"r352",
"r361",
"r362",
"r363",
"r364",
"r365",
"r366",
"r373",
"r420",
"r421",
"r422",
"r437",
"r505"
]
},
"srt_EquityMethodInvesteeNameDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "EquityMethodInvesteeNameDomain",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"auth_ref": [
"r212",
"r213",
"r214"
]
},
"us-gaap_EquityMethodInvestmentOwnershipPercentage": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "EquityMethodInvestmentOwnershipPercentage",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Percent ownership in Xenetic",
"verboseLabel": "Ownership percentage",
"documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
}
}
},
"auth_ref": [
"r212"
]
},
"ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "EquityValuationAssumptionDifferenceFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
}
}
},
"auth_ref": [
"r631"
]
},
"ecd_ErrCompAnalysisTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ErrCompAnalysisTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Erroneous Compensation Analysis [Text Block]"
}
}
},
"auth_ref": [
"r594",
"r606",
"r616",
"r642"
]
},
"ecd_ErrCompRecoveryTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ErrCompRecoveryTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Erroneously Awarded Compensation Recovery [Table]"
}
}
},
"auth_ref": [
"r591",
"r603",
"r613",
"r639"
]
},
"ecd_ExecutiveCategoryAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ExecutiveCategoryAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Executive Category [Axis]"
}
}
},
"auth_ref": [
"r637"
]
},
"xbio_ExerciseOfPurchaseWarrantsValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ExerciseOfPurchaseWarrantsValue",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Exercise of purchase warrants"
}
}
},
"auth_ref": [
]
},
"xbio_ExerciseOfPurchaseWarrantsshares": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ExerciseOfPurchaseWarrantsshares",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Exercise of purchase warrants, shares"
}
}
},
"auth_ref": [
]
},
"dei_Extension": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "Extension",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Extension",
"documentation": "Extension number for local phone number."
}
}
},
"auth_ref": [
]
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r356",
"r357",
"r358"
]
},
"us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value, Recurring and Nonrecurring [Table]",
"documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
}
}
},
"auth_ref": [
"r356",
"r357",
"r358"
]
},
"us-gaap_FairValueByFairValueHierarchyLevelAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueByFairValueHierarchyLevelAxis",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value Hierarchy and NAV [Axis]",
"documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
}
}
},
"auth_ref": [
"r230",
"r250",
"r251",
"r252",
"r253",
"r254",
"r255",
"r357",
"r383",
"r384",
"r385",
"r549",
"r550",
"r553",
"r554",
"r555"
]
},
"us-gaap_FairValueDisclosuresAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueDisclosuresAbstract",
"lang": {
"en-us": {
"role": {
"label": "Fair Value Disclosures [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_FairValueDisclosuresTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueDisclosuresTextBlock",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurements"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value Measurements",
"documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
}
}
},
"auth_ref": [
"r355"
]
},
"us-gaap_FairValueInputsLevel3Member": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueInputsLevel3Member",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value, Inputs, Level 3 [Member]",
"documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
}
}
},
"auth_ref": [
"r230",
"r250",
"r251",
"r252",
"r253",
"r254",
"r255",
"r357",
"r385",
"r549",
"r550",
"r553",
"r554",
"r555"
]
},
"us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueMeasurementsFairValueHierarchyDomain",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
}
}
},
"auth_ref": [
"r230",
"r250",
"r251",
"r252",
"r253",
"r254",
"r255",
"r383",
"r384",
"r385",
"r549",
"r550",
"r553",
"r554",
"r555"
]
},
"us-gaap_FairValueOfFinancialInstrumentsPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FairValueOfFinancialInstrumentsPolicy",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Fair Value of Financial Instruments",
"documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
}
}
},
"auth_ref": [
"r7",
"r18"
]
},
"us-gaap_FinancialInstrumentsOwnedAtFairValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FinancialInstrumentsOwnedAtFairValue",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/FairValueMeasurementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Financial instruments fair value",
"documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings."
}
}
},
"auth_ref": [
"r66"
]
},
"us-gaap_ForeignCurrencyDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ForeignCurrencyDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Functional Currency Change",
"documentation": "The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items."
}
}
},
"auth_ref": [
"r360",
"r367",
"r572",
"r573",
"r574",
"r575",
"r668"
]
},
"us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Foreign Currency Transactions",
"documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
}
}
},
"auth_ref": [
"r360"
]
},
"ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
}
}
},
"auth_ref": [
"r598",
"r610",
"r620",
"r646"
]
},
"ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Expense of Enforcement, Amount"
}
}
},
"auth_ref": [
"r598",
"r610",
"r620",
"r646"
]
},
"ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery due to Violation of Home Country Law, Amount"
}
}
},
"auth_ref": [
"r598",
"r610",
"r620",
"r646"
]
},
"ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
}
}
},
"auth_ref": [
"r598",
"r610",
"r620",
"r646"
]
},
"ecd_ForgoneRecoveryIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "ForgoneRecoveryIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Forgone Recovery, Individual Name"
}
}
},
"auth_ref": [
"r598",
"r610",
"r620",
"r646"
]
},
"us-gaap_FurnitureAndFixturesMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "FurnitureAndFixturesMember",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Furniture and Fixtures [Member]",
"documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
}
}
},
"auth_ref": [
]
},
"country_GB": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/country/2023",
"localname": "GB",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "UNITED KINGDOM"
}
}
},
"auth_ref": [
]
},
"us-gaap_GeneralAndAdministrativeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "GeneralAndAdministrativeExpense",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "General and administrative",
"label": "General and Administrative Expense",
"documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
}
}
},
"auth_ref": [
"r84",
"r485"
]
},
"us-gaap_GeneralAndAdministrativeExpenseMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "GeneralAndAdministrativeExpenseMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "General and Administrative Expense [Member]",
"documentation": "Primary financial statement caption encompassing general and administrative expense."
}
}
},
"auth_ref": [
"r83"
]
},
"us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Indefinite-Lived Intangible Assets",
"documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets."
}
}
},
"auth_ref": [
"r93"
]
},
"dei_IcfrAuditorAttestationFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "IcfrAuditorAttestationFlag",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "ICFR Auditor Attestation Flag"
}
}
},
"auth_ref": [
"r587",
"r589",
"r602"
]
},
"us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Impairment of Long-Lived Assets",
"documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
}
}
},
"auth_ref": [
"r0",
"r95"
]
},
"us-gaap_IncomeStatementAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeStatementAbstract",
"lang": {
"en-us": {
"role": {
"label": "Income Statement [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_IncomeStatementLocationAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeStatementLocationAxis",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Income Statement Location [Axis]",
"documentation": "Information by location in the income statement."
}
}
},
"auth_ref": [
"r218",
"r219",
"r490"
]
},
"us-gaap_IncomeStatementLocationDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeStatementLocationDomain",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"documentation": "Location in the income statement."
}
}
},
"auth_ref": [
"r219",
"r490"
]
},
"us-gaap_IncomeTaxAuthorityAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxAuthorityAxis",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Income Tax Authority [Axis]",
"documentation": "Information by tax jurisdiction."
}
}
},
"auth_ref": [
"r9"
]
},
"us-gaap_IncomeTaxAuthorityDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxAuthorityDomain",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
}
}
},
"auth_ref": [
]
},
"us-gaap_IncomeTaxDisclosureAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxDisclosureAbstract",
"lang": {
"en-us": {
"role": {
"label": "Income Tax Disclosure [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_IncomeTaxDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxes"
],
"lang": {
"en-us": {
"role": {
"label": "Income Taxes",
"documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
}
}
},
"auth_ref": [
"r161",
"r316",
"r323",
"r325",
"r331",
"r335",
"r337",
"r338",
"r339",
"r433"
]
},
"us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Interest and penalties",
"documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations."
}
}
},
"auth_ref": [
"r761"
]
},
"us-gaap_IncomeTaxExpenseBenefit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxExpenseBenefit",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net benefit for income taxes",
"label": "Income Tax Expense (Benefit)",
"documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
}
}
},
"auth_ref": [
"r120",
"r131",
"r175",
"r176",
"r193",
"r321",
"r336",
"r413"
]
},
"us-gaap_IncomeTaxPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Income Taxes",
"label": "Income Tax, Policy [Policy Text Block]",
"documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
}
}
},
"auth_ref": [
"r147",
"r319",
"r320",
"r325",
"r326",
"r330",
"r332",
"r427"
]
},
"us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Change in valuation allowance",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 8.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Rate change",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
}
}
},
"auth_ref": [
"r318",
"r322"
]
},
"us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 5.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Foreign rate differential",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationNondeductibleExpense",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Permanent differences, net",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 6.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Share-based expense, net",
"documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncomeTaxReconciliationOtherAdjustments": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationOtherAdjustments",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": 1.0,
"order": 9.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"label": "Other items",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncomeTaxReconciliationTaxCreditsResearch",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation": {
"parentTag": "us-gaap_IncomeTaxExpenseBenefit",
"weight": -1.0,
"order": 7.0
}
},
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-TaxReconciliation"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Enhanced research and development tax credits",
"label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
"documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
}
}
},
"auth_ref": [
"r760"
]
},
"us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 5.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Prepaid expenses and other",
"label": "Increase (Decrease) in Accounts and Other Receivables",
"documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
}
}
},
"auth_ref": [
"r4"
]
},
"us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 7.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Accounts payable, accrued expenses and other liabilities",
"documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
}
}
},
"auth_ref": [
"r4"
]
},
"us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncreaseDecreaseInOtherNoncurrentAssets",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": -1.0,
"order": 6.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Other long-term assets",
"label": "Increase (Decrease) in Other Noncurrent Assets",
"documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
}
}
},
"auth_ref": [
"r681"
]
},
"us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Changes in operating assets and liabilities:"
}
}
},
"auth_ref": [
]
},
"ecd_IndividualAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "IndividualAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Individual [Axis]"
}
}
},
"auth_ref": [
"r601",
"r610",
"r620",
"r637",
"r646",
"r650",
"r658"
]
},
"ecd_InsiderTradingArrLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "InsiderTradingArrLineItems",
"auth_ref": [
"r656"
]
},
"ecd_InsiderTradingPoliciesProcLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "InsiderTradingPoliciesProcLineItems",
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures [Line Items]"
}
}
},
"auth_ref": [
"r590",
"r662"
]
},
"ecd_InsiderTrdPoliciesProcAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "InsiderTrdPoliciesProcAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
],
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures Adopted [Flag]"
}
}
},
"auth_ref": [
"r590",
"r662"
]
},
"ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
],
"lang": {
"en-us": {
"role": {
"label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
}
}
},
"auth_ref": [
"r590",
"r662"
]
},
"us-gaap_InterestAndFeeIncomeOtherLoans": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "InterestAndFeeIncomeOtherLoans",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Interest and fee income, other loans",
"documentation": "Amount of interest and fee income from loans classified as other."
}
}
},
"auth_ref": [
"r116"
]
},
"us-gaap_InterestIncomeExpenseNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "InterestIncomeExpenseNet",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"label": "Interest income, net",
"documentation": "The net amount of operating interest income (expense)."
}
}
},
"auth_ref": [
"r117"
]
},
"us-gaap_InterestPaidNet": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "InterestPaidNet",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Cash paid for interest",
"documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
}
}
},
"auth_ref": [
"r153",
"r155",
"r156"
]
},
"xbio_IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "IssuanceOfCommonStockToAcquireInprocessResearchAndDevelopment",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock to acquire in-process research and development"
}
}
},
"auth_ref": [
]
},
"xbio_IssuanceOfCommonStockToAdjustForReverseSplitRounding": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "IssuanceOfCommonStockToAdjustForReverseSplitRounding",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock to adjust for reverse split rounding"
}
}
},
"auth_ref": [
]
},
"xbio_IssuanceOfCommonStockToAdjustForReverseSplitRoundingShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "IssuanceOfCommonStockToAdjustForReverseSplitRoundingShares",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock to adjust for reverse split rounding, shares"
}
}
},
"auth_ref": [
]
},
"xbio_IssuanceOfCommonStockToAdjustForReverseStockSplit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "IssuanceOfCommonStockToAdjustForReverseStockSplit",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock to adjust for Reverse Stock Split"
}
}
},
"auth_ref": [
]
},
"xbio_JSOPMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "JSOPMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "JSOP [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_LeaseExpirationDate1": {
"xbrltype": "dateItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LeaseExpirationDate1",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Lease termination date",
"documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format."
}
}
},
"auth_ref": [
]
},
"us-gaap_LeaseholdImprovementsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LeaseholdImprovementsMember",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Leasehold Improvements [Member]",
"documentation": "Additions or improvements to assets held under a lease arrangement."
}
}
},
"auth_ref": [
"r94"
]
},
"dei_LegalEntityAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "LegalEntityAxis",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Legal Entity [Axis]",
"documentation": "The set of legal entities associated with a report."
}
}
},
"auth_ref": [
]
},
"us-gaap_LesseeOperatingLeaseDescription": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LesseeOperatingLeaseDescription",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Lessee, Operating Lease, Description",
"documentation": "Description of lessee's operating lease."
}
}
},
"auth_ref": [
"r370"
]
},
"us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Future minimum rental payments",
"documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
}
}
},
"auth_ref": [
"r372"
]
},
"us-gaap_LesseeOperatingLeaseTermOfContract": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LesseeOperatingLeaseTermOfContract",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Lease term",
"documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
}
}
},
"auth_ref": [
"r772"
]
},
"us-gaap_LesseeOperatingLeasesTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LesseeOperatingLeasesTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Leases",
"documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
}
}
},
"auth_ref": [
"r368"
]
},
"us-gaap_Liabilities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "Liabilities",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total liabilities",
"label": "Liabilities",
"documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
}
}
},
"auth_ref": [
"r22",
"r160",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r342",
"r343",
"r344",
"r359",
"r459",
"r546",
"r571",
"r694",
"r774",
"r775"
]
},
"us-gaap_LiabilitiesAndStockholdersEquity": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LiabilitiesAndStockholdersEquity",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total liabilities and stockholders' equity",
"label": "Liabilities and Equity",
"documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
}
}
},
"auth_ref": [
"r78",
"r114",
"r409",
"r560",
"r684",
"r690",
"r771"
]
},
"us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LiabilitiesAndStockholdersEquityAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "LIABILITIES AND STOCKHOLDERS' EQUITY"
}
}
},
"auth_ref": [
]
},
"us-gaap_LiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_Liabilities",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total current liabilities",
"label": "Liabilities, Current",
"documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
}
}
},
"auth_ref": [
"r24",
"r137",
"r160",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r342",
"r343",
"r344",
"r359",
"r560",
"r694",
"r774",
"r775"
]
},
"us-gaap_LiabilitiesCurrentAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LiabilitiesCurrentAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Current liabilities:"
}
}
},
"auth_ref": [
]
},
"us-gaap_LiabilityForUncertainTaxPositionsCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "LiabilityForUncertainTaxPositionsCurrent",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Uncertain tax positions",
"documentation": "Amount recognized for uncertainty in income taxes classified as current."
}
}
},
"auth_ref": [
"r23"
]
},
"xbio_LicensingArrangementsTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "LicensingArrangementsTextBlock",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangements"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Licensing Arrangements",
"label": "LicensingArrangementsTextBlock"
}
}
},
"auth_ref": [
]
},
"dei_LocalPhoneNumber": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "LocalPhoneNumber",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Local Phone Number",
"documentation": "Local phone number for entity."
}
}
},
"auth_ref": [
]
},
"ecd_MeasureAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "MeasureAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Measure [Axis]"
}
}
},
"auth_ref": [
"r629"
]
},
"ecd_MeasureName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "MeasureName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Measure Name"
}
}
},
"auth_ref": [
"r629"
]
},
"ecd_MnpiDiscTimedForCompValFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "MnpiDiscTimedForCompValFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "MNPI Disclosure Timed for Compensation Value [Flag]"
}
}
},
"auth_ref": [
"r649"
]
},
"xbio_MonthlyPayment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "MonthlyPayment",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Monthly payment"
}
}
},
"auth_ref": [
]
},
"ecd_MtrlTermsOfTrdArrTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "MtrlTermsOfTrdArrTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Material Terms of Trading Arrangement"
}
}
},
"auth_ref": [
"r657"
]
},
"ecd_NamedExecutiveOfficersFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NamedExecutiveOfficersFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Named Executive Officers, Footnote [Text Block]"
}
}
},
"auth_ref": [
"r630"
]
},
"us-gaap_NetCashProvidedByUsedInInvestingActivities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NetCashProvidedByUsedInInvestingActivities",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net cash used in investing activities",
"label": "Net Cash Provided by (Used in) Investing Activities",
"documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
}
}
},
"auth_ref": [
"r154"
]
},
"us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM INVESTING ACTIVITIES:"
}
}
},
"auth_ref": [
]
},
"us-gaap_NetCashProvidedByUsedInOperatingActivities": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NetCashProvidedByUsedInOperatingActivities",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net cash used in operating activities",
"label": "Net Cash Provided by (Used in) Operating Activities",
"documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
}
}
},
"auth_ref": [
"r87",
"r88",
"r89"
]
},
"us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "CASH FLOWS FROM OPERATING ACTIVITIES:"
}
}
},
"auth_ref": [
]
},
"us-gaap_NetIncomeLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NetIncomeLoss",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 1.0
},
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": null,
"weight": null,
"order": null,
"root": true
}
},
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure",
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows",
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Net loss",
"label": "Net loss",
"verboseLabel": "Net Income (Loss) Attributable to Parent",
"terseLabel": "Net income (loss)",
"documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
}
}
},
"auth_ref": [
"r82",
"r89",
"r115",
"r135",
"r145",
"r146",
"r150",
"r160",
"r167",
"r169",
"r170",
"r171",
"r172",
"r175",
"r176",
"r181",
"r190",
"r201",
"r205",
"r207",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r354",
"r359",
"r411",
"r482",
"r503",
"r504",
"r547",
"r570",
"r694"
]
},
"us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Recent Accounting Standards",
"documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
}
}
},
"auth_ref": [
]
},
"dei_NoTradingSymbolFlag": {
"xbrltype": "trueItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "NoTradingSymbolFlag",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "No Trading Symbol Flag",
"documentation": "Boolean flag that is true only for a security having no trading symbol."
}
}
},
"auth_ref": [
]
},
"xbio_NonEmployeeStockOptionsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "NonEmployeeStockOptionsMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Non Employee Stock Options [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_NonGaapMeasureDescriptionTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NonGaapMeasureDescriptionTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-GAAP Measure Description [Text Block]"
}
}
},
"auth_ref": [
"r629"
]
},
"ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NonPeoNeoAvgCompActuallyPaidAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-PEO NEO Average Compensation Actually Paid Amount"
}
}
},
"auth_ref": [
"r627"
]
},
"ecd_NonPeoNeoAvgTotalCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NonPeoNeoAvgTotalCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Non-PEO NEO Average Total Compensation Amount"
}
}
},
"auth_ref": [
"r626"
]
},
"ecd_NonRule10b51ArrAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NonRule10b51ArrAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Non-Rule 10b5-1 Arrangement Adopted"
}
}
},
"auth_ref": [
"r657"
]
},
"ecd_NonRule10b51ArrTrmntdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "NonRule10b51ArrTrmntdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Non-Rule 10b5-1 Arrangement Terminated"
}
}
},
"auth_ref": [
"r657"
]
},
"xbio_NonVestedEmployeeStockOptionMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "NonVestedEmployeeStockOptionMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Non Vested Employee Stock Option [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_NonoperatingIncomeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NonoperatingIncomeExpense",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total other income, net",
"label": "Nonoperating Income (Expense)",
"documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
}
}
},
"auth_ref": [
"r85"
]
},
"us-gaap_NonoperatingIncomeExpenseAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "NonoperatingIncomeExpenseAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"label": "Other income (expense):"
}
}
},
"auth_ref": [
]
},
"xbio_NoteReceivableInterestRate": {
"xbrltype": "percentItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "NoteReceivableInterestRate",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Accrued interest rate"
}
}
},
"auth_ref": [
]
},
"xbio_OfficeAndComputerEquipmentMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "OfficeAndComputerEquipmentMember",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Office And Computer Equipment [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_OfficeSpaceMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "OfficeSpaceMember",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Office Space [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_OfficeSpaceMiamiFlMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "OfficeSpaceMiamiFlMember",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Office Space Miami Fl [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_OffsettingAssetsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OffsettingAssetsLineItems",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Offsetting Assets [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
]
},
"us-gaap_OffsettingAssetsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OffsettingAssetsTable",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Offsetting Assets [Table]",
"documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements."
}
}
},
"auth_ref": [
"r79",
"r80"
]
},
"us-gaap_OperatingCostsAndExpensesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingCostsAndExpensesAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"label": "Operating costs and expenses:"
}
}
},
"auth_ref": [
]
},
"us-gaap_OperatingExpenses": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingExpenses",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": -1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"negatedTotalLabel": "Total operating costs and expenses",
"label": "Operating Expenses",
"documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
}
}
},
"auth_ref": [
]
},
"us-gaap_OperatingIncomeLoss": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingIncomeLoss",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_NetIncomeLoss",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Loss from operations",
"label": "Operating Income (Loss)",
"documentation": "The net result for the period of deducting operating expenses from operating revenues."
}
}
},
"auth_ref": [
"r190",
"r201",
"r205",
"r207",
"r547"
]
},
"us-gaap_OperatingLeasePayments": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingLeasePayments",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetails-CashFlowInformation"
],
"lang": {
"en-us": {
"role": {
"label": "Cash paid for amounts included in the measurement of lease liabilities",
"documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
}
}
},
"auth_ref": [
"r369",
"r371"
]
},
"us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Amortization of right of use asset",
"documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
}
}
},
"auth_ref": [
"r682"
]
},
"us-gaap_OperatingLossCarryforwards": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingLossCarryforwards",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Net operating loss carryforwards",
"documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
}
}
},
"auth_ref": [
"r58"
]
},
"xbio_OperatingLossCarryforwardsExpirationDate1": {
"xbrltype": "stringItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "OperatingLossCarryforwardsExpirationDate1",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Operating loss carryforwards expiration date"
}
}
},
"auth_ref": [
]
},
"us-gaap_OperatingLossCarryforwardsLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingLossCarryforwardsLineItems",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Operating Loss Carryforwards [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
]
},
"us-gaap_OperatingLossCarryforwardsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OperatingLossCarryforwardsTable",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Operating Loss Carryforwards [Table]",
"documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
}
}
},
"auth_ref": [
"r57"
]
},
"us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_OtherAccruedLiabilitiesCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherAccruedLiabilitiesCurrent",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/AccruedExpensesDetails": {
"parentTag": "us-gaap_AccruedLiabilitiesCurrent",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Other",
"documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
}
}
},
"auth_ref": [
"r23"
]
},
"us-gaap_OtherAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherAssets",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Other assets",
"label": "Other Assets [Default Label]",
"documentation": "Amount of assets classified as other."
}
}
},
"auth_ref": [
"r111",
"r138",
"r401",
"r571"
]
},
"us-gaap_OtherAssetsDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherAssetsDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/OtherAssets"
],
"lang": {
"en-us": {
"role": {
"label": "Other Assets",
"documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
}
}
},
"auth_ref": [
]
},
"us-gaap_OtherAssetsNoncurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherAssetsNoncurrent",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_Assets",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Other assets",
"documentation": "Amount of noncurrent assets classified as other."
}
}
},
"auth_ref": [
"r138"
]
},
"us-gaap_OtherNonoperatingIncomeExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherNonoperatingIncomeExpense",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_NonoperatingIncomeExpense",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"label": "Other income (expense)",
"documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
}
}
},
"auth_ref": [
"r86"
]
},
"ecd_OtherPerfMeasureAmt": {
"xbrltype": "decimalItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "OtherPerfMeasureAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Other Performance Measure Amount"
}
}
},
"auth_ref": [
"r629"
]
},
"us-gaap_OtherPrepaidExpenseCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherPrepaidExpenseCurrent",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Prepaid expenses and other current asset",
"documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
}
}
},
"auth_ref": [
"r676",
"r691"
]
},
"dei_OtherReportingStandardItemNumber": {
"xbrltype": "otherReportingStandardItemNumberItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "OtherReportingStandardItemNumber",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Other Reporting Standard Item Number",
"documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
}
}
},
"auth_ref": [
"r589"
]
},
"us-gaap_OtherResearchAndDevelopmentExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "OtherResearchAndDevelopmentExpense",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Initial payment for research",
"documentation": "Amount of other research and development expense."
}
}
},
"auth_ref": [
"r759"
]
},
"xbio_OtherWarrantsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "OtherWarrantsMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Other Warrants [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_OutstandingAggtErrCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "OutstandingAggtErrCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Aggregate Erroneous Compensation Amount"
}
}
},
"auth_ref": [
"r596",
"r608",
"r618",
"r644"
]
},
"ecd_OutstandingRecoveryCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "OutstandingRecoveryCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Recovery Compensation Amount"
}
}
},
"auth_ref": [
"r599",
"r611",
"r621",
"r647"
]
},
"ecd_OutstandingRecoveryIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "OutstandingRecoveryIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Outstanding Recovery, Individual Name"
}
}
},
"auth_ref": [
"r599",
"r611",
"r621",
"r647"
]
},
"xbio_PatentAssignmentMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PatentAssignmentMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Patent Assignment [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_PayVsPerformanceDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PayVsPerformanceDisclosureLineItems",
"auth_ref": [
"r625"
]
},
"us-gaap_PayablesAndAccrualsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PayablesAndAccrualsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Payables and Accruals [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_PaymentsForFees": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PaymentsForFees",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "One-time fee",
"documentation": "Amount of cash outflow for fees classified as other."
}
}
},
"auth_ref": [
"r3"
]
},
"us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
"weight": -1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Net cash paid to acquire in-process research and development",
"label": "Payments to Acquire in Process Research and Development",
"documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination."
}
}
},
"auth_ref": [
"r32"
]
},
"us-gaap_PaymentsToAcquireNotesReceivable": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PaymentsToAcquireNotesReceivable",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Payments to acquire notes receivable",
"documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
}
}
},
"auth_ref": [
"r31"
]
},
"us-gaap_PaymentsToAcquireProductiveAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PaymentsToAcquireProductiveAssets",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Cash payment",
"documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
}
}
},
"auth_ref": [
"r119",
"r766",
"r767",
"r768"
]
},
"ecd_PeerGroupIssuersFnTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PeerGroupIssuersFnTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Peer Group Issuers, Footnote [Text Block]"
}
}
},
"auth_ref": [
"r628"
]
},
"ecd_PeerGroupTotalShareholderRtnAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PeerGroupTotalShareholderRtnAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Peer Group Total Shareholder Return Amount"
}
}
},
"auth_ref": [
"r628"
]
},
"ecd_PeoActuallyPaidCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PeoActuallyPaidCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Actually Paid Compensation Amount"
}
}
},
"auth_ref": [
"r627"
]
},
"ecd_PeoName": {
"xbrltype": "normalizedStringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PeoName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Name"
}
}
},
"auth_ref": [
"r630"
]
},
"ecd_PeoTotalCompAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PeoTotalCompAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "PEO Total Compensation Amount"
}
}
},
"auth_ref": [
"r626"
]
},
"xbio_PharmsynthezMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PharmsynthezMember",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Pharmsynthez [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_Plan401KMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "Plan401KMember",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Plan 401 K [Member]"
}
}
},
"auth_ref": [
]
},
"dei_PreCommencementIssuerTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "PreCommencementIssuerTenderOffer",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Issuer Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
}
}
},
"auth_ref": [
"r583"
]
},
"dei_PreCommencementTenderOffer": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "PreCommencementTenderOffer",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Pre-commencement Tender Offer",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
}
}
},
"auth_ref": [
"r584"
]
},
"us-gaap_PreferredStockDividendRatePercentage": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockDividendRatePercentage",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Dividend rate",
"documentation": "The percentage rate used to calculate dividend payments on preferred stock."
}
}
},
"auth_ref": [
"r234",
"r513",
"r515",
"r517",
"r519"
]
},
"us-gaap_PreferredStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred Stock [Member]",
"documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
}
}
},
"auth_ref": [
"r562",
"r563",
"r566",
"r567",
"r568",
"r569",
"r778",
"r780"
]
},
"us-gaap_PreferredStockParOrStatedValuePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockParOrStatedValuePerShare",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock, par value",
"documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
}
}
},
"auth_ref": [
"r72",
"r233"
]
},
"us-gaap_PreferredStockSharesAuthorized": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockSharesAuthorized",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock, shares authorized",
"documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
}
}
},
"auth_ref": [
"r72",
"r461"
]
},
"us-gaap_PreferredStockSharesIssued": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockSharesIssued",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock, shares issued",
"documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
}
}
},
"auth_ref": [
"r72",
"r233"
]
},
"us-gaap_PreferredStockSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockSharesOutstanding",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock, shares outstanding",
"documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
}
}
},
"auth_ref": [
"r72",
"r461",
"r480",
"r780",
"r781"
]
},
"xbio_PreferredStockStatedValuePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PreferredStockStatedValuePerShare",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock stated value per share",
"documentation": "Preferred stock stated value per share"
}
}
},
"auth_ref": [
]
},
"us-gaap_PreferredStockValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredStockValue",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock, value",
"documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
}
}
},
"auth_ref": [
"r72",
"r405",
"r560"
]
},
"us-gaap_PreferredUnitsAuthorized": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredUnitsAuthorized",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock share authorized",
"documentation": "The number of preferred units authorized to be issued."
}
}
},
"auth_ref": [
"r100"
]
},
"us-gaap_PreferredUnitsIssued": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredUnitsIssued",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock issued",
"documentation": "The number of preferred units issued."
}
}
},
"auth_ref": [
"r100"
]
},
"us-gaap_PreferredUnitsOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PreferredUnitsOutstanding",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Preferred stock outstanding",
"documentation": "The number of preferred units outstanding."
}
}
},
"auth_ref": [
"r100"
]
},
"us-gaap_PrepaidExpenseAndOtherAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PrepaidExpenseAndOtherAssets",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"verboseLabel": "Prepaid expenses and other",
"label": "Prepaid Expense and Other Assets",
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets."
}
}
},
"auth_ref": [
]
},
"us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PrepaidExpenseAndOtherAssetsCurrent",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_AssetsCurrent",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Prepaid expenses and other",
"verboseLabel": "Prepaid expenses and other current assets",
"terseLabel": "Prepaid expenses and other current",
"documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
}
}
},
"auth_ref": [
"r677"
]
},
"us-gaap_PrepaidExpenseNoncurrent": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PrepaidExpenseNoncurrent",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Prepaid clinical supply",
"documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
}
}
},
"auth_ref": [
"r673"
]
},
"xbio_PreparationOfInterimFinancialStatementsPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PreparationOfInterimFinancialStatementsPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Preparation of Financial Statements"
}
}
},
"auth_ref": [
]
},
"us-gaap_PrivatePlacementMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PrivatePlacementMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Private Placement [Member]",
"documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
}
}
},
"auth_ref": [
]
},
"srt_ProductOrServiceAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "ProductOrServiceAxis",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Product and Service [Axis]"
}
}
},
"auth_ref": [
"r208",
"r386",
"r414",
"r415",
"r416",
"r417",
"r418",
"r419",
"r538",
"r551",
"r561",
"r670",
"r692",
"r693",
"r697",
"r777"
]
},
"srt_ProductsAndServicesDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "ProductsAndServicesDomain",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"auth_ref": [
"r208",
"r386",
"r414",
"r415",
"r416",
"r417",
"r418",
"r419",
"r538",
"r551",
"r561",
"r670",
"r692",
"r693",
"r697",
"r777"
]
},
"us-gaap_ProfessionalAndContractServicesExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ProfessionalAndContractServicesExpense",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Consulting, transaction and development costs",
"documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support."
}
}
},
"auth_ref": [
]
},
"us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertyPlantAndEquipmentByTypeAxis",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Long-Lived Tangible Asset [Axis]",
"documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
}
}
},
"auth_ref": [
"r6"
]
},
"xbio_PropertyPlantAndEquipmentEstimatedUsefulLives1": {
"xbrltype": "stringItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PropertyPlantAndEquipmentEstimatedUsefulLives1",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Estimated useful life"
}
}
},
"auth_ref": [
]
},
"us-gaap_PropertyPlantAndEquipmentLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertyPlantAndEquipmentLineItems",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Property, Plant and Equipment [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
]
},
"us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertyPlantAndEquipmentPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Property and Equipment",
"documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
}
}
},
"auth_ref": [
"r6",
"r127",
"r130",
"r410"
]
},
"us-gaap_PropertyPlantAndEquipmentTypeDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertyPlantAndEquipmentTypeDomain",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
}
}
},
"auth_ref": [
"r94"
]
},
"us-gaap_PropertySubjectToOrAvailableForOperatingLeaseAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertySubjectToOrAvailableForOperatingLeaseAxis",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Property Subject to or Available for Operating Lease [Axis]",
"documentation": "Information by property that could be leased or is available for lease."
}
}
},
"auth_ref": [
"r118"
]
},
"us-gaap_PropertySubjectToOrAvailableForOperatingLeaseDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "PropertySubjectToOrAvailableForOperatingLeaseDomain",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "A descriptive title of whether the property is subject to or available for operating lease."
}
}
},
"auth_ref": [
"r118"
]
},
"xbio_PubliclyTradedWarrantsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PubliclyTradedWarrantsMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Publicly Traded Warrants [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_PurchaseWarrantsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "PurchaseWarrantsMember",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Purchase Warrants"
}
}
},
"auth_ref": [
]
},
"ecd_PvpTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PvpTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pay vs Performance Disclosure [Table]"
}
}
},
"auth_ref": [
"r625"
]
},
"ecd_PvpTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "PvpTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Pay vs Performance [Table Text Block]"
}
}
},
"auth_ref": [
"r625"
]
},
"ecd_RecoveryOfErrCompDisclosureLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "RecoveryOfErrCompDisclosureLineItems",
"auth_ref": [
"r591",
"r603",
"r613",
"r639"
]
},
"us-gaap_RelatedPartyDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RelatedPartyDomain",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"auth_ref": [
"r256",
"r377",
"r378",
"r454",
"r455",
"r456",
"r457",
"r458",
"r479",
"r481",
"r512"
]
},
"us-gaap_RelatedPartyTransactionLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RelatedPartyTransactionLineItems",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transaction [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r486",
"r487",
"r490"
]
},
"us-gaap_RelatedPartyTransactionsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RelatedPartyTransactionsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RelatedPartyTransactionsByRelatedPartyAxis",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party, Type [Axis]",
"documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
}
}
},
"auth_ref": [
"r256",
"r377",
"r378",
"r387",
"r388",
"r389",
"r390",
"r391",
"r392",
"r393",
"r394",
"r395",
"r396",
"r397",
"r398",
"r454",
"r455",
"r456",
"r457",
"r458",
"r479",
"r481",
"r512",
"r773"
]
},
"us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RelatedPartyTransactionsDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactions"
],
"lang": {
"en-us": {
"role": {
"label": "Related Party Transactions",
"documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
}
}
},
"auth_ref": [
"r374",
"r375",
"r376",
"r378",
"r380",
"r434",
"r435",
"r436",
"r488",
"r489",
"r490",
"r509",
"r511"
]
},
"srt_RepurchaseAgreementCounterpartyNameDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "RepurchaseAgreementCounterpartyNameDomain",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"auth_ref": [
"r162",
"r163",
"r229",
"r235",
"r379",
"r541",
"r542"
]
},
"us-gaap_ResearchAndDevelopmentExpense": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ResearchAndDevelopmentExpense",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_OperatingExpenses",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss",
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Research and development",
"label": "Research and development expenses",
"verboseLabel": "Research and development costs",
"documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
}
}
},
"auth_ref": [
"r69",
"r315",
"r776"
]
},
"us-gaap_ResearchAndDevelopmentExpenseMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ResearchAndDevelopmentExpenseMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Research and Development Expense [Member]",
"documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
}
}
},
"auth_ref": [
]
},
"us-gaap_ResearchAndDevelopmentExpensePolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ResearchAndDevelopmentExpensePolicy",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Research and Development Expenses",
"documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
}
}
},
"auth_ref": [
"r314"
]
},
"xbio_ResearchAndDevelopmentExpensesMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ResearchAndDevelopmentExpensesMember",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Research And Development Expenses [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_ResearchAndDevelopmentsInProcess": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ResearchAndDevelopmentsInProcess",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows": {
"parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
"weight": 1.0,
"order": 2.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "Acquired in-process research and development"
}
}
},
"auth_ref": [
]
},
"ecd_RestatementDateAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "RestatementDateAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Determination Date [Axis]"
}
}
},
"auth_ref": [
"r592",
"r604",
"r614",
"r640"
]
},
"ecd_RestatementDeterminationDate": {
"xbrltype": "dateItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "RestatementDeterminationDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Determination Date"
}
}
},
"auth_ref": [
"r593",
"r605",
"r615",
"r641"
]
},
"ecd_RestatementDoesNotRequireRecoveryTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "RestatementDoesNotRequireRecoveryTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Restatement Does Not Require Recovery [Text Block]"
}
}
},
"auth_ref": [
"r600",
"r612",
"r622",
"r648"
]
},
"us-gaap_RestrictedStockUnitsRSUMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RestrictedStockUnitsRSUMember",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Restricted Stock Units (RSUs) [Member]",
"documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
}
}
},
"auth_ref": [
]
},
"us-gaap_RetainedEarningsAccumulatedDeficit": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RetainedEarningsAccumulatedDeficit",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": 1.0,
"order": 4.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Accumulated deficit",
"documentation": "Amount of accumulated undistributed earnings (deficit)."
}
}
},
"auth_ref": [
"r75",
"r98",
"r408",
"r423",
"r425",
"r432",
"r462",
"r560"
]
},
"us-gaap_RetainedEarningsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RetainedEarningsMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Retained Earnings [Member]",
"documentation": "Accumulated undistributed earnings (deficit)."
}
}
},
"auth_ref": [
"r134",
"r164",
"r165",
"r166",
"r168",
"r174",
"r176",
"r216",
"r217",
"r306",
"r307",
"r308",
"r333",
"r334",
"r345",
"r347",
"r348",
"r350",
"r352",
"r420",
"r422",
"r437",
"r780"
]
},
"us-gaap_RetirementPlanNameAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RetirementPlanNameAxis",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Retirement Plan Name [Axis]",
"documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
}
}
},
"auth_ref": [
"r258",
"r259",
"r260",
"r261",
"r262",
"r263",
"r264",
"r265",
"r266",
"r557",
"r669",
"r698",
"r699",
"r700",
"r701",
"r702",
"r703",
"r704",
"r705",
"r706",
"r707",
"r708",
"r709",
"r710",
"r711",
"r712",
"r713",
"r714",
"r715",
"r716",
"r717",
"r718",
"r719",
"r720",
"r721",
"r722",
"r723",
"r724",
"r725",
"r726",
"r727",
"r728",
"r729",
"r730",
"r731",
"r732",
"r733",
"r734",
"r735",
"r736",
"r737",
"r738",
"r739",
"r740",
"r741",
"r742",
"r743",
"r744",
"r745",
"r746",
"r747",
"r748",
"r749",
"r750",
"r751",
"r752",
"r753",
"r754",
"r755",
"r756",
"r757"
]
},
"us-gaap_RetirementPlanNameDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RetirementPlanNameDomain",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans."
}
}
},
"auth_ref": [
"r258",
"r259",
"r260",
"r261",
"r262",
"r263",
"r264",
"r265",
"r266",
"r557",
"r669",
"r698",
"r699",
"r700",
"r701",
"r702",
"r703",
"r704",
"r705",
"r706",
"r707",
"r708",
"r709",
"r710",
"r711",
"r712",
"r713",
"r714",
"r715",
"r716",
"r717",
"r718",
"r719",
"r720",
"r721",
"r722",
"r723",
"r724",
"r725",
"r726",
"r727",
"r728",
"r729",
"r730",
"r731",
"r732",
"r733",
"r734",
"r735",
"r736",
"r737",
"r738",
"r739",
"r740",
"r741",
"r742",
"r743",
"r744",
"r745",
"r746",
"r747",
"r748",
"r749",
"r750",
"r751",
"r752",
"r753",
"r754",
"r755",
"r756",
"r757"
]
},
"us-gaap_RevenueRecognitionPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RevenueRecognitionPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Revenue Recognition",
"documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
}
}
},
"auth_ref": [
"r484",
"r537",
"r544"
]
},
"us-gaap_Revenues": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "Revenues",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_OperatingIncomeLoss",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total revenue",
"label": "Revenues",
"documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
}
}
},
"auth_ref": [
"r151",
"r160",
"r191",
"r192",
"r200",
"r203",
"r204",
"r208",
"r209",
"r211",
"r215",
"r220",
"r221",
"r222",
"r223",
"r224",
"r225",
"r226",
"r227",
"r228",
"r359",
"r400",
"r694"
]
},
"us-gaap_RevenuesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RevenuesAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss"
],
"lang": {
"en-us": {
"role": {
"label": "Revenue"
}
}
},
"auth_ref": [
]
},
"us-gaap_RisksAndUncertaintiesAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RisksAndUncertaintiesAbstract",
"lang": {
"en-us": {
"role": {
"label": "Risks and Uncertainties [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_RoyaltyIncomeNonoperating": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "RoyaltyIncomeNonoperating",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss": {
"parentTag": "us-gaap_Revenues",
"weight": 1.0,
"order": 1.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLoss",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Royalty revenue",
"verboseLabel": "Revenue",
"documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources."
}
}
},
"auth_ref": [
"r85"
]
},
"xbio_RoyaltyRevenueMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "RoyaltyRevenueMember",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Royalty Revenue [Member]"
}
}
},
"auth_ref": [
]
},
"ecd_Rule10b51ArrAdoptedFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "Rule10b51ArrAdoptedFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Rule 10b5-1 Arrangement Adopted"
}
}
},
"auth_ref": [
"r657"
]
},
"ecd_Rule10b51ArrTrmntdFlag": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "Rule10b51ArrTrmntdFlag",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Rule 10b5-1 Arrangement Terminated"
}
}
},
"auth_ref": [
"r657"
]
},
"us-gaap_SaleOfStockPricePerShare": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SaleOfStockPricePerShare",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Price per share",
"documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
}
}
},
"auth_ref": [
]
},
"us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/AccruedExpensesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of accrued expenses",
"documentation": "Tabular disclosure of the components of accrued liabilities."
}
}
},
"auth_ref": [
]
},
"us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
"presentation": [
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
"documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
}
}
},
"auth_ref": [
"r340"
]
},
"us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Share-Based Compensation Expense",
"documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
}
}
},
"auth_ref": [
"r53"
]
},
"us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of deferred tax assets and liabilities",
"documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
}
}
},
"auth_ref": [
"r109"
]
},
"us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
"presentation": [
"http://xeneticbio.com/role/EmployeeBenefitPlansDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Defined Benefit Plans Disclosures [Table]",
"documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
}
}
},
"auth_ref": [
"r8",
"r46",
"r47",
"r48",
"r49"
]
},
"us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of reconciliation of income tax provision",
"documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
}
}
},
"auth_ref": [
"r108"
]
},
"us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
"documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
}
}
},
"auth_ref": [
"r53"
]
},
"srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Investment, Name [Axis]"
}
}
},
"auth_ref": [
"r212",
"r213",
"r214"
]
},
"us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of components of loss before income taxes",
"documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
}
}
},
"auth_ref": [
"r685"
]
},
"us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of non-vested options",
"documentation": "Tabular disclosure of the changes in outstanding nonvested shares."
}
}
},
"auth_ref": [
"r52"
]
},
"us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfPropertyPlantAndEquipmentTable",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetails"
],
"lang": {
"en-us": {
"role": {
"label": "Property, Plant and Equipment [Table]",
"documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
}
}
},
"auth_ref": [
"r6"
]
},
"us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Related Party Transactions, by Related Party [Table]",
"documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
}
}
},
"auth_ref": [
"r64",
"r65",
"r486",
"r487",
"r490"
]
},
"us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
"documentation": "Disclosure of information about share-based payment arrangement."
}
}
},
"auth_ref": [
"r268",
"r270",
"r272",
"r273",
"r274",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r282",
"r283",
"r284",
"r285",
"r286",
"r287",
"r288",
"r289",
"r290",
"r291",
"r292",
"r293",
"r296",
"r297",
"r298",
"r299",
"r300"
]
},
"us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of option activity",
"documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
}
}
},
"auth_ref": [
"r16",
"r17",
"r51"
]
},
"us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Schedule of assumptions used",
"documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
}
}
},
"auth_ref": [
"r107"
]
},
"xbio_ScrippsAgreementMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ScrippsAgreementMember",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Scripps Agreement [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_ScrippsResearchMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "ScrippsResearchMember",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Scripps Research [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_SecuritiesFinancingTransactionAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SecuritiesFinancingTransactionAxis",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Securities Financing Transaction [Axis]",
"documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost."
}
}
},
"auth_ref": [
"r110"
]
},
"us-gaap_SecuritiesFinancingTransactionTypeDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SecuritiesFinancingTransactionTypeDomain",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Measurement of financing transaction securities held."
}
}
},
"auth_ref": [
"r110"
]
},
"dei_Security12bTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "Security12bTitle",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(b) Security",
"documentation": "Title of a 12(b) registered security."
}
}
},
"auth_ref": [
"r577"
]
},
"dei_Security12gTitle": {
"xbrltype": "securityTitleItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "Security12gTitle",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Title of 12(g) Security",
"documentation": "Title of a 12(g) registered security."
}
}
},
"auth_ref": [
"r581"
]
},
"dei_SecurityExchangeName": {
"xbrltype": "edgarExchangeCodeItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "SecurityExchangeName",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Exchange Name",
"documentation": "Name of the Exchange on which a security is registered."
}
}
},
"auth_ref": [
"r580"
]
},
"dei_SecurityReportingObligation": {
"xbrltype": "securityReportingObligationItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "SecurityReportingObligation",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Security Reporting Obligation",
"documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
}
}
},
"auth_ref": [
"r585"
]
},
"srt_SegmentGeographicalDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "SegmentGeographicalDomain",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions"
],
"auth_ref": [
"r209",
"r210",
"r450",
"r451",
"r452",
"r514",
"r516",
"r518",
"r520",
"r528",
"r529",
"r530",
"r531",
"r532",
"r533",
"r534",
"r535",
"r536",
"r539",
"r552",
"r564",
"r697",
"r777"
]
},
"us-gaap_SegmentReportingPolicyPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SegmentReportingPolicyPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Segment Information",
"documentation": "Disclosure of accounting policy for segment reporting."
}
}
},
"auth_ref": [
"r194",
"r195",
"r196",
"r197",
"r198",
"r199",
"r209",
"r548"
]
},
"us-gaap_SeriesAPreferredStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SeriesAPreferredStockMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Series A Preferred Stock [Member]",
"documentation": "Series A preferred stock."
}
}
},
"auth_ref": [
"r674",
"r675",
"r696"
]
},
"xbio_SeriesAWarrantsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "SeriesAWarrantsMember",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Series A Warrants [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_SeriesBPreferredStockMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SeriesBPreferredStockMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Series B Preferred Stock [Member]",
"documentation": "Series B preferred stock."
}
}
},
"auth_ref": [
"r674",
"r675",
"r696"
]
},
"xbio_SerumInstituteMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "SerumInstituteMember",
"presentation": [
"http://xeneticbio.com/role/OtherAssetsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Serum Institute [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_ShareBasedCompensation": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensation",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-ShareBasedExpense"
],
"lang": {
"en-us": {
"role": {
"label": "Share-based compensation",
"documentation": "Amount of noncash expense for share-based payment arrangement."
}
}
},
"auth_ref": [
"r4"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common stock awards granted",
"documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
}
}
},
"auth_ref": [
"r287"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Other than options, grant date fair value per share",
"documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
}
}
},
"auth_ref": [
"r287"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price",
"documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award."
}
}
},
"auth_ref": [
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average expected dividend yield",
"documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
}
}
},
"auth_ref": [
"r298"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average expected volatility",
"documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
}
}
},
"auth_ref": [
"r297"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
"xbrltype": "percentItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average risk-free interest rate",
"documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
}
}
},
"auth_ref": [
"r299"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"http://xeneticbio.com/role/Share-basedExpenseTables"
],
"lang": {
"en-us": {
"role": {
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r268",
"r270",
"r272",
"r273",
"r274",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r282",
"r283",
"r284",
"r285",
"r286",
"r287",
"r288",
"r289",
"r290",
"r291",
"r292",
"r293",
"r296",
"r297",
"r298",
"r299",
"r300"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants exercised",
"documentation": "Number of non-option equity instruments exercised by participants."
}
}
},
"auth_ref": [
"r14"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Other than options, shares expired",
"documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed."
}
}
},
"auth_ref": [
"r15"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Other than options, shares outstanding",
"documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
}
}
},
"auth_ref": [
"r12",
"r13"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Options exercisable",
"documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
}
}
},
"auth_ref": [
"r278"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price, exercisable",
"documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
}
}
},
"auth_ref": [
"r278"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Options expired",
"negatedLabel": "Options expired",
"documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
}
}
},
"auth_ref": [
"r283"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Options forfeited",
"documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
}
}
},
"auth_ref": [
"r282"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Options granted",
"documentation": "Net number of share options (or share units) granted during the period."
}
}
},
"auth_ref": [
"r758"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average grant date fair value per share, options granted",
"verboseLabel": "Weighted average grant date fair value",
"documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
}
}
},
"auth_ref": [
"r290"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Aggregate intrinsic value, outstanding beginning balance",
"periodEndLabel": "Aggregate intrinsic value, outstanding ending balance",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
"documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
}
}
},
"auth_ref": [
"r50"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Options outstanding, beginning balance",
"periodEndLabel": "Options outstanding, ending balance",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
"documentation": "Number of options outstanding, including both vested and non-vested options."
}
}
},
"auth_ref": [
"r276",
"r277"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Weighted-average exercise price outstanding, beginning balance",
"periodEndLabel": "Weighted-average exercise price, ending balance",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
"documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
}
}
},
"auth_ref": [
"r276",
"r277"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate intrinsic value, vested or expected to vest",
"documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
}
}
},
"auth_ref": [
"r293"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price, vested or expected to vest",
"documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
}
}
},
"auth_ref": [
"r293"
]
},
"us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Options vested or expected to vest",
"documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
}
}
},
"auth_ref": [
"r292"
]
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee",
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative",
"http://xeneticbio.com/role/Share-basedExpenseTables",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Award under share-based payment arrangement."
}
}
},
"auth_ref": [
"r272",
"r273",
"r274",
"r276",
"r277",
"r278",
"r279",
"r280",
"r281",
"r282",
"r283",
"r284",
"r285",
"r286",
"r287",
"r288",
"r289",
"r290",
"r291",
"r292",
"r293",
"r296",
"r297",
"r298",
"r299",
"r300"
]
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price, expired",
"documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired."
}
}
},
"auth_ref": [
"r283"
]
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price, forfeited/expired",
"documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
}
}
},
"auth_ref": [
"r282"
]
},
"us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average exercise price, granted",
"documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
}
}
},
"auth_ref": [
"r280"
]
},
"us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Share-based Expense",
"documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
}
}
},
"auth_ref": [
"r267",
"r275",
"r294",
"r295",
"r296",
"r297",
"r300",
"r309",
"r310",
"r311",
"r312"
]
},
"us-gaap_SharePrice": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharePrice",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Bid price, per share",
"documentation": "Price of a single share of a number of saleable stocks of a company."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-AssumptionsEmployee"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average expected life of option",
"documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
}
}
},
"auth_ref": [
"r296"
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
"crdr": "debit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate intrinsic value, exercisable",
"documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
}
}
},
"auth_ref": [
"r50"
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Non-vested options outstanding, beginning balance",
"periodEndLabel": "Non-vested options outstanding, ending balance",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
"documentation": "Number of non-vested options outstanding."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average grant date fair value per share, options forfeited",
"documentation": "Weighted average grant-date fair value of non-vested options forfeited."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Non-vested weighted-average grant date fair value per share, beginning balance",
"periodEndLabel": "Non-vested weighted-average grant date fair value per share, ending balance",
"label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
"documentation": "Weighted average grant-date fair value of non-vested options outstanding."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average remaining life outstanding ending",
"documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
}
}
},
"auth_ref": [
"r105"
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average remaining life, vested or expected to vest",
"documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
}
}
},
"auth_ref": [
"r293"
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Fair value of options vested",
"documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
}
}
},
"auth_ref": [
"r291"
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Options vested",
"label": "Options vested",
"documentation": "Number of options vested."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
"xbrltype": "perShareItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-vestedEmployeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average grant date fair value per share, options vested",
"documentation": "Weighted average grant-date fair value of options vested."
}
}
},
"auth_ref": [
]
},
"us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
"xbrltype": "durationItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetails-EmployeeOptionActivity",
"http://xeneticbio.com/role/Share-basedExpenseDetails-Non-employeeOptionActivity"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average remaining life, exercisable",
"documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
}
}
},
"auth_ref": [
"r106"
]
},
"us-gaap_SharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SharesOutstanding",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"periodStartLabel": "Beginning balance, shares",
"periodEndLabel": "Ending balance, shares",
"label": "Shares, Outstanding",
"documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
}
}
},
"auth_ref": [
]
},
"us-gaap_SignificantAccountingPoliciesTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SignificantAccountingPoliciesTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Summary of Significant Accounting Policies",
"documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
}
}
},
"auth_ref": [
"r90",
"r158"
]
},
"dei_SolicitingMaterial": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "SolicitingMaterial",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Soliciting Material",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
}
}
},
"auth_ref": [
"r586"
]
},
"xbio_SponsoredResearchAgreementMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "SponsoredResearchAgreementMember",
"presentation": [
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Sponsored Research Agreement [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_StateAndLocalJurisdictionMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StateAndLocalJurisdictionMember",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "State and Local Jurisdiction [Member]",
"documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
}
}
},
"auth_ref": [
]
},
"us-gaap_StatementClassOfStockAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementClassOfStockAxis",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/Cover",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Class of Stock [Axis]",
"documentation": "Information by the different classes of stock of the entity."
}
}
},
"auth_ref": [
"r133",
"r140",
"r141",
"r142",
"r160",
"r179",
"r180",
"r182",
"r184",
"r188",
"r189",
"r215",
"r220",
"r222",
"r223",
"r224",
"r227",
"r228",
"r233",
"r234",
"r237",
"r240",
"r246",
"r359",
"r428",
"r429",
"r430",
"r431",
"r437",
"r438",
"r439",
"r440",
"r441",
"r442",
"r443",
"r444",
"r445",
"r446",
"r447",
"r449",
"r461",
"r483",
"r505",
"r521",
"r522",
"r523",
"r524",
"r525",
"r667",
"r683",
"r689"
]
},
"us-gaap_StatementEquityComponentsAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementEquityComponentsAxis",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Equity Components [Axis]",
"documentation": "Information by component of equity."
}
}
},
"auth_ref": [
"r11",
"r27",
"r134",
"r148",
"r149",
"r150",
"r164",
"r165",
"r166",
"r168",
"r174",
"r176",
"r187",
"r216",
"r217",
"r248",
"r306",
"r307",
"r308",
"r333",
"r334",
"r345",
"r346",
"r347",
"r348",
"r349",
"r350",
"r352",
"r361",
"r362",
"r363",
"r364",
"r365",
"r366",
"r373",
"r420",
"r421",
"r422",
"r437",
"r505"
]
},
"srt_StatementGeographicalAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/srt/2023",
"localname": "StatementGeographicalAxis",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions"
],
"lang": {
"en-us": {
"role": {
"label": "Geographical [Axis]"
}
}
},
"auth_ref": [
"r209",
"r210",
"r450",
"r451",
"r452",
"r514",
"r516",
"r518",
"r520",
"r527",
"r528",
"r529",
"r530",
"r531",
"r532",
"r533",
"r534",
"r535",
"r536",
"r539",
"r552",
"r564",
"r697",
"r777"
]
},
"us-gaap_StatementLineItems": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementLineItems",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative",
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/Cover",
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Statement [Line Items]",
"documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
}
}
},
"auth_ref": [
"r164",
"r165",
"r166",
"r187",
"r386",
"r426",
"r449",
"r453",
"r454",
"r455",
"r456",
"r457",
"r458",
"r461",
"r464",
"r465",
"r466",
"r467",
"r468",
"r470",
"r471",
"r472",
"r473",
"r475",
"r476",
"r477",
"r478",
"r479",
"r481",
"r484",
"r485",
"r491",
"r492",
"r493",
"r494",
"r495",
"r496",
"r497",
"r498",
"r499",
"r500",
"r501",
"r502",
"r505",
"r565"
]
},
"us-gaap_StatementOfCashFlowsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementOfCashFlowsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Statement of Cash Flows [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_StatementOfFinancialPositionAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementOfFinancialPositionAbstract",
"auth_ref": [
]
},
"us-gaap_StatementOfStockholdersEquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementOfStockholdersEquityAbstract",
"auth_ref": [
]
},
"us-gaap_StatementTable": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StatementTable",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetailsNarrative",
"http://xeneticbio.com/role/CompanyDetailsNarrative",
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedBalanceSheetsParenthetical",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/Cover",
"http://xeneticbio.com/role/IncomeTaxesDetails-DeferredTaxAssets",
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Statement [Table]",
"documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
}
}
},
"auth_ref": [
"r164",
"r165",
"r166",
"r187",
"r386",
"r426",
"r449",
"r453",
"r454",
"r455",
"r456",
"r457",
"r458",
"r461",
"r464",
"r465",
"r466",
"r467",
"r468",
"r470",
"r471",
"r472",
"r473",
"r475",
"r476",
"r477",
"r478",
"r479",
"r481",
"r484",
"r485",
"r491",
"r492",
"r493",
"r494",
"r495",
"r496",
"r497",
"r498",
"r499",
"r500",
"r501",
"r502",
"r505",
"r565"
]
},
"ecd_StkPrcOrTsrEstimationMethodTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "StkPrcOrTsrEstimationMethodTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Stock Price or TSR Estimation Method [Text Block]"
}
}
},
"auth_ref": [
"r595",
"r607",
"r617",
"r643"
]
},
"us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Converted shares",
"documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
}
}
},
"auth_ref": [
"r11",
"r26",
"r43",
"r98",
"r231"
]
},
"us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodSharesNewIssues",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Number of shares issued",
"documentation": "Number of new stock issued during the period."
}
}
},
"auth_ref": [
"r11",
"r72",
"r73",
"r98",
"r428",
"r505",
"r522"
]
},
"us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Common shares issued",
"documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
}
}
},
"auth_ref": [
]
},
"us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity",
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock in connection with purchase of in-process research and development, shares",
"verboseLabel": "Issuance of common stock to adjust for reverse split rounding, shares",
"documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
}
}
},
"auth_ref": [
"r11"
]
},
"us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
"presentation": [
"http://xeneticbio.com/role/Share-basedExpenseDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Options exercised",
"documentation": "Number of share options (or share units) exercised during the current period."
}
}
},
"auth_ref": [
"r11",
"r72",
"r73",
"r98",
"r281"
]
},
"us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockIssuedDuringPeriodValuePurchaseOfAssets",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Number of shares purchase of asset, value",
"documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination."
}
}
},
"auth_ref": [
]
},
"xbio_StockIssuedDuringPeriodValueReverseStockSplits": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "StockIssuedDuringPeriodValueReverseStockSplits",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Issuance of common stock in connection with purchase of in-process research and development",
"documentation": "Issuance of common stock to adjust for reverse split rounding"
}
}
},
"auth_ref": [
]
},
"us-gaap_StockholdersEquity": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockholdersEquity",
"crdr": "credit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
"weight": 1.0,
"order": 3.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets",
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"totalLabel": "Total stockholders' equity",
"periodStartLabel": "Beginning balance, value",
"periodEndLabel": "Ending balance, value",
"label": "Equity, Attributable to Parent",
"documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
}
}
},
"auth_ref": [
"r73",
"r76",
"r77",
"r92",
"r463",
"r480",
"r506",
"r507",
"r560",
"r571",
"r684",
"r690",
"r771",
"r780"
]
},
"us-gaap_StockholdersEquityAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockholdersEquityAbstract",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"label": "Stockholders' equity:"
}
}
},
"auth_ref": [
]
},
"us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockholdersEquityNoteDisclosureTextBlock",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Stockholders\u2019 Equity",
"documentation": "The entire disclosure for equity."
}
}
},
"auth_ref": [
"r97",
"r159",
"r232",
"r234",
"r236",
"r237",
"r238",
"r239",
"r240",
"r241",
"r242",
"r243",
"r244",
"r245",
"r248",
"r351",
"r508",
"r510",
"r526"
]
},
"us-gaap_StockholdersEquityNoteStockSplit": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "StockholdersEquityNoteStockSplit",
"presentation": [
"http://xeneticbio.com/role/CompanyDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Reverse stock split",
"documentation": "Description of the stock split arrangement. Also provide the retroactive effect given by a stock split that occurs after the balance date but before the release of financial statements."
}
}
},
"auth_ref": [
"r99"
]
},
"xbio_SublicenseAgreementSharesMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "SublicenseAgreementSharesMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Sublicense Agreement Shares [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_SublicenseAndLicenseAgreementsMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "SublicenseAndLicenseAgreementsMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Sublicense And License Agreements [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_SubsequentEventsAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SubsequentEventsAbstract",
"lang": {
"en-us": {
"role": {
"label": "Subsequent Events [Abstract]"
}
}
},
"auth_ref": [
]
},
"us-gaap_SubsequentEventsTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SubsequentEventsTextBlock",
"presentation": [
"http://xeneticbio.com/role/SubsequentEvents"
],
"lang": {
"en-us": {
"role": {
"label": "Subsequent Events",
"documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
}
}
},
"auth_ref": [
"r381",
"r382"
]
},
"us-gaap_SupplementalCashFlowInformationAbstract": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "SupplementalCashFlowInformationAbstract",
"presentation": [
"http://xeneticbio.com/role/CommitmentsAndContingenciesDetails-CashFlowInformation",
"http://xeneticbio.com/role/ConsolidatedStatementsOfCashFlows"
],
"lang": {
"en-us": {
"role": {
"label": "SUPPLEMENTAL CASH FLOW INFORMATION:",
"verboseLabel": "Operating cash flow information:"
}
}
},
"auth_ref": [
]
},
"ecd_TabularListTableTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TabularListTableTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Tabular List [Table Text Block]"
}
}
},
"auth_ref": [
"r636"
]
},
"xbio_TakedaMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "TakedaMember",
"presentation": [
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Takeda [Member]"
}
}
},
"auth_ref": [
]
},
"xbio_TheCompanyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "TheCompanyTextBlock",
"presentation": [
"http://xeneticbio.com/role/Company"
],
"lang": {
"en-us": {
"role": {
"label": "The Company"
}
}
},
"auth_ref": [
]
},
"ecd_TotalShareholderRtnAmt": {
"xbrltype": "monetaryItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TotalShareholderRtnAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Total Shareholder Return Amount"
}
}
},
"auth_ref": [
"r628"
]
},
"ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TotalShareholderRtnVsPeerGroupTextBlock",
"presentation": [
"http://xbrl.sec.gov/ecd/role/PvpDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Total Shareholder Return Vs Peer Group [Text Block]"
}
}
},
"auth_ref": [
"r635"
]
},
"ecd_TradingArrAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TradingArrAxis",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangement [Axis]"
}
}
},
"auth_ref": [
"r656"
]
},
"ecd_TradingArrByIndTable": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TradingArrByIndTable",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Arrangements, by Individual [Table]"
}
}
},
"auth_ref": [
"r658"
]
},
"dei_TradingSymbol": {
"xbrltype": "tradingSymbolItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "TradingSymbol",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Trading Symbol",
"documentation": "Trading symbol of an instrument as listed on an exchange."
}
}
},
"auth_ref": [
]
},
"us-gaap_TransactionDomain": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "TransactionDomain",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"documentation": "Agreement between buyer and seller for the exchange of financial instruments."
}
}
},
"auth_ref": [
"r542"
]
},
"us-gaap_TransactionTypeAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "TransactionTypeAxis",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative",
"http://xeneticbio.com/role/RelatedPartyTransactionsDetailsNarrative",
"http://xeneticbio.com/role/SignificantStrategicCollaborationsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Transaction Type [Axis]",
"documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments."
}
}
},
"auth_ref": [
"r542"
]
},
"ecd_TrdArrAdoptionDate": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrAdoptionDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Adoption Date"
}
}
},
"auth_ref": [
"r659"
]
},
"ecd_TrdArrDuration": {
"xbrltype": "durationItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrDuration",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Arrangement Duration"
}
}
},
"auth_ref": [
"r660"
]
},
"ecd_TrdArrIndName": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrIndName",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Name"
}
}
},
"auth_ref": [
"r658"
]
},
"ecd_TrdArrIndTitle": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrIndTitle",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Title"
}
}
},
"auth_ref": [
"r658"
]
},
"ecd_TrdArrSecuritiesAggAvailAmt": {
"xbrltype": "sharesItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrSecuritiesAggAvailAmt",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Aggregate Available"
}
}
},
"auth_ref": [
"r661"
]
},
"ecd_TrdArrTerminationDate": {
"xbrltype": "stringItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "TrdArrTerminationDate",
"presentation": [
"http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
],
"lang": {
"en-us": {
"role": {
"label": "Termination Date"
}
}
},
"auth_ref": [
"r659"
]
},
"us-gaap_TreasuryStockCommonMember": {
"xbrltype": "domainItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "TreasuryStockCommonMember",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfStockholdersEquity"
],
"lang": {
"en-us": {
"role": {
"label": "Treasury Stock, Common [Member]",
"documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
}
}
},
"auth_ref": [
"r44"
]
},
"us-gaap_TreasuryStockCommonValue": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "TreasuryStockCommonValue",
"crdr": "debit",
"calculation": {
"http://xeneticbio.com/role/ConsolidatedBalanceSheets": {
"parentTag": "us-gaap_StockholdersEquity",
"weight": -1.0,
"order": 6.0
}
},
"presentation": [
"http://xeneticbio.com/role/ConsolidatedBalanceSheets"
],
"lang": {
"en-us": {
"role": {
"negatedLabel": "Treasury stock",
"label": "Treasury Stock, Common, Value",
"documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
}
}
},
"auth_ref": [
"r28",
"r44",
"r45"
]
},
"us-gaap_TypeOfArrangementAxis": {
"xbrltype": "stringItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "TypeOfArrangementAxis",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
"documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
}
}
},
"auth_ref": [
"r340"
]
},
"country_US": {
"xbrltype": "domainItemType",
"nsuri": "http://xbrl.sec.gov/country/2023",
"localname": "US",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetails-IncomeByGeographicRegions",
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "UNITED STATES"
}
}
},
"auth_ref": [
]
},
"ecd_UndrlygSecurityMktPriceChngPct": {
"xbrltype": "pureItemType",
"nsuri": "http://xbrl.sec.gov/ecd/2023",
"localname": "UndrlygSecurityMktPriceChngPct",
"presentation": [
"http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
],
"lang": {
"en-us": {
"role": {
"label": "Underlying Security Market Price Change, Percent"
}
}
},
"auth_ref": [
"r655"
]
},
"us-gaap_UnrecognizedTaxBenefits": {
"xbrltype": "monetaryItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "UnrecognizedTaxBenefits",
"crdr": "credit",
"presentation": [
"http://xeneticbio.com/role/IncomeTaxesDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Unrecognized tax benefits",
"documentation": "Amount of unrecognized tax benefits."
}
}
},
"auth_ref": [
"r317",
"r324"
]
},
"us-gaap_UseOfEstimates": {
"xbrltype": "textBlockItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "UseOfEstimates",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Use of Estimates",
"documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
}
}
},
"auth_ref": [
"r39",
"r40",
"r41",
"r123",
"r125",
"r128",
"r129"
]
},
"xbio_VolitionMember": {
"xbrltype": "domainItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "VolitionMember",
"presentation": [
"http://xeneticbio.com/role/LicensingArrangementsDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Volition [Member]"
}
}
},
"auth_ref": [
]
},
"us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
"xbrltype": "dateItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "WarrantsAndRightsOutstandingMaturityDate",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Maturity date",
"documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format."
}
}
},
"auth_ref": [
"r770"
]
},
"xbio_WarrantsExercisedShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "WarrantsExercisedShares",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants exercised shares"
}
}
},
"auth_ref": [
]
},
"xbio_WarrantsForfeitedShares": {
"xbrltype": "sharesItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "WarrantsForfeitedShares",
"presentation": [
"http://xeneticbio.com/role/StockholdersEquityDetailsNarrative"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants forfeited shares"
}
}
},
"auth_ref": [
]
},
"xbio_WarrantsPolicyTextBlock": {
"xbrltype": "textBlockItemType",
"nsuri": "http://xeneticbio.com/20231231",
"localname": "WarrantsPolicyTextBlock",
"presentation": [
"http://xeneticbio.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
],
"lang": {
"en-us": {
"role": {
"label": "Warrants"
}
}
},
"auth_ref": [
]
},
"us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLossParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average shares of common stock outstanding, diluted",
"documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
}
}
},
"auth_ref": [
"r178",
"r184"
]
},
"us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
"xbrltype": "sharesItemType",
"nsuri": "http://fasb.org/us-gaap/2023",
"localname": "WeightedAverageNumberOfSharesOutstandingBasic",
"presentation": [
"http://xeneticbio.com/role/ConsolidatedStatementsOfComprehensiveLossParenthetical"
],
"lang": {
"en-us": {
"role": {
"label": "Weighted-average shares of common stock outstanding, basic",
"documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
}
}
},
"auth_ref": [
"r177",
"r184"
]
},
"dei_WrittenCommunications": {
"xbrltype": "booleanItemType",
"nsuri": "http://xbrl.sec.gov/dei/2023",
"localname": "WrittenCommunications",
"presentation": [
"http://xeneticbio.com/role/Cover"
],
"lang": {
"en-us": {
"role": {
"label": "Written Communications",
"documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
}
}
},
"auth_ref": [
"r665"
]
}
}
}
},
"std_ref": {
"r0": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "05",
"Paragraph": "4",
"SubTopic": "10",
"Topic": "360",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
},
"r1": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"SubTopic": "230",
"Topic": "830",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
},
"r2": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "10A",
"SubTopic": "10",
"Topic": "220",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
},
"r3": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(g)",
"SubTopic": "10",
"Topic": "230",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
},
"r4": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(a)",
"SubTopic": "10",
"Topic": "230",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
},
"r5": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(b)",
"SubTopic": "10",
"Topic": "230",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
},
"r6": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"SubTopic": "10",
"Topic": "360",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
},
"r7": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"SubTopic": "10",
"Topic": "825",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
},
"r8": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"SubTopic": "20",
"Topic": "715",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r9": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(e)",
"SubTopic": "10",
"Topic": "740",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
},
"r10": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1A",
"Subparagraph": "(c),(3)",
"SubTopic": "10",
"Topic": "810",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
},
"r11": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"SubTopic": "10",
"Topic": "505",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
},
"r12": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(i)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r13": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(ii)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r14": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(2)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r15": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(4)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r16": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r17": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)",
"SubTopic": "10",
"Topic": "718",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r18": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Section": "60",
"Paragraph": "1",
"SubTopic": "10",
"Topic": "820",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
},
"r19": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r20": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19(a),20,24)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r21": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19,20)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r22": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.19-26)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r23": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.20)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r24": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.21)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r25": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.25)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r26": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.29-30)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r27": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.29-31)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r28": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "210",
"SubTopic": "10",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02.30)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r29": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "45",
"Paragraph": "14",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
},
"r30": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "220",
"SubTopic": "10",
"Section": "45",
"Paragraph": "14A",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
},
"r31": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "13",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
},
"r32": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "13",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
},
"r33": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "45",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
},
"r34": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
},
"r35": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
},
"r36": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "230",
"SubTopic": "10",
"Section": "50",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
},
"r37": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
},
"r38": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "260",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
},
"r39": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
},
"r40": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
},
"r41": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "275",
"SubTopic": "10",
"Section": "50",
"Paragraph": "9",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
},
"r42": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "360",
"SubTopic": "10",
"Section": "45",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4"
},
"r43": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
},
"r44": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "30",
"Section": "45",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
},
"r45": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "505",
"SubTopic": "30",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
},
"r46": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
},
"r47": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
},
"r48": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
},
"r49": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "715",
"SubTopic": "20",
"Section": "55",
"Paragraph": "17",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
},
"r50": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r51": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r52": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r53": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "10",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(h)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r54": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "20",
"Section": "55",
"Paragraph": "12",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
},
"r55": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "718",
"SubTopic": "20",
"Section": "55",
"Paragraph": "13",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
},
"r56": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "45",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
},
"r57": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
},
"r58": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
},
"r59": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "740",
"SubTopic": "10",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
},
"r60": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "805",
"SubTopic": "10",
"Section": "05",
"Paragraph": "4",
"Subparagraph": "(a)-(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4"
},
"r61": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "810",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
},
"r62": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4A",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
},
"r63": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "815",
"SubTopic": "10",
"Section": "50",
"Paragraph": "4B",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
},
"r64": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
},
"r65": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "850",
"SubTopic": "10",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
},
"r66": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "940",
"SubTopic": "320",
"Section": "45",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-2"
},
"r67": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "210",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03.17)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
},
"r68": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "942",
"SubTopic": "825",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
},
"r69": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Name": "Accounting Standards Codification",
"Topic": "985",
"SubTopic": "20",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
},
"r70": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(26)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r71": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(26)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r72": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(28))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r73": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(29))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r74": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30)(a)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r75": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30)(a)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r76": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r77": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(31))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r78": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(32))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r79": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
},
"r80": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "210",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4"
},
"r81": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "11",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
},
"r82": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(20))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r83": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r84": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r85": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r86": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03.9)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r87": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "24",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
},
"r88": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
},
"r89": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
},
"r90": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "235",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//235/tableOfContent"
},
"r91": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "275",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//275/tableOfContent"
},
"r92": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "310",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SAB Topic 4.E)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
},
"r93": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "350",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
},
"r94": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "360",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
},
"r95": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "360",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SAB Topic 5.CC)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
},
"r96": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "440",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//440/tableOfContent"
},
"r97": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "505",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//505/tableOfContent"
},
"r98": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.3-04)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
},
"r99": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "4",
"Subparagraph": "(SAB Topic 4.C)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
},
"r100": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "5",
"Subparagraph": "(SAB Topic 4.F)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
},
"r101": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "710",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//710/tableOfContent"
},
"r102": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "712",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//712/tableOfContent"
},
"r103": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "715",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//715/tableOfContent"
},
"r104": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "718",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//718/tableOfContent"
},
"r105": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "718",
"SubTopic": "10",
"Subparagraph": "(e)(1)",
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Section": "50",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r106": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "718",
"SubTopic": "10",
"Subparagraph": "(e)(2)",
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Section": "50",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r107": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "718",
"SubTopic": "10",
"Subparagraph": "(f)(2)",
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Section": "50",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r108": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Paragraph": "12",
"Section": "50",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
},
"r109": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Paragraph": "2",
"Section": "50",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
},
"r110": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "860",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1A",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
},
"r111": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(10))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
},
"r112": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(11))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
},
"r113": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(15)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
},
"r114": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-03(23))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
},
"r115": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04(22))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
},
"r116": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04.1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
},
"r117": {
"role": "http://fasb.org/us-gaap/role/ref/legacyRef",
"Topic": "942",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04.10)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
},
"r118": {
"role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
"Topic": "840",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4"
},
"r119": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "13",
"Subparagraph": "(c)",
"SubTopic": "10",
"Topic": "230",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
},
"r120": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "2",
"Subparagraph": "(a)",
"SubTopic": "20",
"Topic": "740",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
},
"r121": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "20",
"SubTopic": "210",
"Topic": "946",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
},
"r122": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"SubTopic": "10",
"Topic": "808",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
},
"r123": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"SubTopic": "10",
"Topic": "275",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
},
"r124": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"SubTopic": "10",
"Topic": "808",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
},
"r125": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"SubTopic": "10",
"Topic": "275",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
},
"r126": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)",
"SubTopic": "10",
"Topic": "275",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
},
"r127": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)",
"SubTopic": "360",
"Topic": "958",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
},
"r128": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"SubTopic": "10",
"Topic": "275",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
},
"r129": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "12",
"SubTopic": "10",
"Topic": "275",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
},
"r130": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"SubTopic": "360",
"Topic": "958",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
},
"r131": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(h))",
"SubTopic": "10",
"Topic": "235",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r132": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Accounting Standards Codification",
"Topic": "808",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//808/tableOfContent"
},
"r133": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Name": "Regulation S-K (SK)",
"Number": "229",
"Section": "1402",
"Paragraph": "(a)",
"Publisher": "SEC"
},
"r134": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "105",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
},
"r135": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "205",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
},
"r136": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
},
"r137": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
},
"r138": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(17))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r139": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(18))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r140": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(27)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r141": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(28))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r142": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(29))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r143": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(30)(a)(4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r144": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(9))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r145": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1A",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
},
"r146": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1B",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
},
"r147": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
},
"r148": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
},
"r149": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
},
"r150": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
},
"r151": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r152": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.5-03(25))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
},
"r153": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "17",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
},
"r154": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "24",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
},
"r155": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
},
"r156": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
},
"r157": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
},
"r158": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
},
"r159": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(e)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r160": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r161": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(h)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r162": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(m)(1)(iii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r163": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(m)(2)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r164": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "23",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
},
"r165": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "24",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
},
"r166": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "5",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
},
"r167": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
},
"r168": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
},
"r169": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
},
"r170": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
},
"r171": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
},
"r172": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
},
"r173": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
},
"r174": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
},
"r175": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
},
"r176": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "9",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
},
"r177": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "10",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
},
"r178": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "16",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
},
"r179": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
},
"r180": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
},
"r181": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "60B",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
},
"r182": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "60B",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
},
"r183": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "7",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
},
"r184": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
},
"r185": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
},
"r186": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "15",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
},
"r187": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "272",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
},
"r188": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "272",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
},
"r189": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "272",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
},
"r190": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "22",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
},
"r191": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
},
"r192": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
},
"r193": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "22",
"Subparagraph": "(h)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
},
"r194": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r195": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r196": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r197": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r198": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r199": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "29",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
},
"r200": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
},
"r201": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
},
"r202": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
},
"r203": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
},
"r204": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
},
"r205": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
},
"r206": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
},
"r207": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "32",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
},
"r208": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "40",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
},
"r209": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "41",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
},
"r210": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "41",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
},
"r211": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "42",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
},
"r212": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
},
"r213": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
},
"r214": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
},
"r215": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
},
"r216": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "326",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "4",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
},
"r217": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "326",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "5",
"Subparagraph": "(c)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
},
"r218": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "360",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
},
"r219": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "420",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
},
"r220": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r221": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r222": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iv))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r223": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r224": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
},
"r225": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
},
"r226": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
},
"r227": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(4)(iv))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
},
"r228": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1B",
"Subparagraph": "(SX 210.13-02(a)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
},
"r229": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1B",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
},
"r230": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1D",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
},
"r231": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1E",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
},
"r232": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r233": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r234": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r235": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r236": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(g)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r237": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(h)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r238": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Subparagraph": "(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
},
"r239": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
},
"r240": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
},
"r241": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "14",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
},
"r242": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "16",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
},
"r243": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
},
"r244": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
},
"r245": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "18",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
},
"r246": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
},
"r247": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
},
"r248": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.3-04)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
},
"r249": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r250": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r251": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r252": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(A)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r253": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(B)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r254": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(C)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r255": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r256": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(n)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r257": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r258": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r259": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r260": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r261": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r262": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(e)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r263": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(e)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r264": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(f)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r265": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(f)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r266": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Subparagraph": "(f)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
},
"r267": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//718/tableOfContent"
},
"r268": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "35",
"Paragraph": "1D",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
},
"r269": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "35",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
},
"r270": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "35",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
},
"r271": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r272": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r273": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r274": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r275": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r276": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r277": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r278": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r279": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r280": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r281": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r282": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r283": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(04)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r284": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r285": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r286": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r287": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r288": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r289": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(2)(iii)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r290": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r291": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r292": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r293": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r294": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r295": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r296": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r297": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r298": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r299": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r300": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(f)(2)(v)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r301": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(h)(1)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r302": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(h)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r303": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(h)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r304": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r305": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(l)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r306": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
},
"r307": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(f)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
},
"r308": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "15",
"Subparagraph": "(f)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
},
"r309": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.C.Q3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
},
"r310": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.D.1.Q5)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
},
"r311": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.D.2.Q6)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
},
"r312": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.D.3.Q2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
},
"r313": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 14.F)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
},
"r314": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "730",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "05",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
},
"r315": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "730",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
},
"r316": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//740/tableOfContent"
},
"r317": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "10B",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
},
"r318": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "15",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-15"
},
"r319": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
},
"r320": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
},
"r321": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "10",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
},
"r322": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "12",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
},
"r323": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "14",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
},
"r324": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "15A",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
},
"r325": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "17",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
},
"r326": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "19",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
},
"r327": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
},
"r328": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
},
"r329": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
},
"r330": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "20",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
},
"r331": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "21",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
},
"r332": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "9",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
},
"r333": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(d)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
},
"r334": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "8",
"Subparagraph": "(d)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
},
"r335": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
},
"r336": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB TOPIC 6.I.7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
},
"r337": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SAB Topic 11.C)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
},
"r338": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "270",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
},
"r339": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "740",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
},
"r340": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "808",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
},
"r341": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "810",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
},
"r342": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "810",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "25",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
},
"r343": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "810",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(bb)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
},
"r344": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "810",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
},
"r345": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r346": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(h)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r347": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(h)(1)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r348": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(h)(1)(iii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r349": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(h)(1)(iv)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r350": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "6",
"Subparagraph": "(i)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
},
"r351": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
},
"r352": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
},
"r353": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
},
"r354": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
},
"r355": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "820",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
},
"r356": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "820",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
},
"r357": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "820",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
},
"r358": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "820",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
},
"r359": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "825",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
},
"r360": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//830/tableOfContent"
},
"r361": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "17",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
},
"r362": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
},
"r363": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
},
"r364": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
},
"r365": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "20",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
},
"r366": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
},
"r367": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "830",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479424/830-30-S99-1"
},
"r368": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//842-20/tableOfContent"
},
"r369": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "5",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
},
"r370": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
},
"r371": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(g)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
},
"r372": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
},
"r373": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "848",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(a)(3)(iii)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
},
"r374": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//850/tableOfContent"
},
"r375": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
},
"r376": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
},
"r377": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
},
"r378": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
},
"r379": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
},
"r380": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
},
"r381": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "855",
"Name": "Accounting Standards Codification",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//855/tableOfContent"
},
"r382": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "855",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
},
"r383": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "860",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(bb)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
},
"r384": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "860",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(bb)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
},
"r385": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "860",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(bb)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
},
"r386": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "924",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 11.L)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
},
"r387": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
},
"r388": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
},
"r389": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "20",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
},
"r390": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "20",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
},
"r391": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
},
"r392": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
},
"r393": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "33",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
},
"r394": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "33",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
},
"r395": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "35A",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
},
"r396": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "35A",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
},
"r397": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Subparagraph": "(c)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
},
"r398": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "932",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Subparagraph": "(c)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
},
"r399": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "942",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-04(27))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
},
"r400": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "942",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.9-05(b)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
},
"r401": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(10))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r402": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(12))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r403": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(19))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r404": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r405": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(21))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r406": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(22))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r407": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r408": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r409": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(25))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r410": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-03(a)(8)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
},
"r411": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(18))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
},
"r412": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(23))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
},
"r413": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.7-04(9))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
},
"r414": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column A))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r415": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column B))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r416": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column C))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r417": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column D))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r418": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column E))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r419": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-17(Column F))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
},
"r420": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r421": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r422": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(f)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r423": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r424": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(g)(2)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r425": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "944",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "2",
"Subparagraph": "(h)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
},
"r426": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r427": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(h)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r428": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(i)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r429": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(i)(2)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r430": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(i)(2)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r431": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-03(i)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
},
"r432": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "11",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
},
"r433": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "13",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
},
"r434": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
},
"r435": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
},
"r436": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
},
"r437": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "4",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
},
"r438": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
},
"r439": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "27",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
},
"r440": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r441": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r442": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r443": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r444": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r445": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r446": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(g)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r447": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(h)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
},
"r448": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "21",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
},
"r449": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
},
"r450": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
},
"r451": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
},
"r452": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
},
"r453": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r454": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(12)(b)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r455": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(12)(b)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r456": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(12)(b)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r457": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(13)(a)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r458": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(13)(a)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r459": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(14))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r460": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(15))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r461": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(16)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r462": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(17))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r463": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(19))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r464": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(2)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r465": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(2)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r466": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(3)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r467": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(3)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r468": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(3)(c))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r469": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r470": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(6)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r471": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(6)(c))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r472": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(6)(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r473": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(6)(e))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r474": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(8))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r475": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(9)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r476": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(9)(c))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r477": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(9)(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r478": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(9)(e))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r479": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.6-05(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
},
"r480": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.6-05(4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
},
"r481": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "3",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
},
"r482": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "7",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
},
"r483": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
},
"r484": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r485": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r486": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r487": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r488": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(c))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r489": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(e))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r490": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(2)(g)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r491": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r492": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r493": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r494": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r495": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(6))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r496": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(a)(7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r497": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r498": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r499": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r500": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r501": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(6))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r502": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(7)(c)(7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r503": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-07(9))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
},
"r504": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(1)(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
},
"r505": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(4)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
},
"r506": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(6))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
},
"r507": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
},
"r508": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
},
"r509": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
},
"r510": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
},
"r511": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "235",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
},
"r512": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "310",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
},
"r513": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
},
"r514": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
},
"r515": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
},
"r516": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
},
"r517": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
},
"r518": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
},
"r519": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "6",
"Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
},
"r520": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "6",
"Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
},
"r521": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
},
"r522": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
},
"r523": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
},
"r524": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
},
"r525": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
},
"r526": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "946",
"SubTopic": "505",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
},
"r527": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "948",
"SubTopic": "310",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-29(Footnote 4))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
},
"r528": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column B))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r529": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column C))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r530": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column D))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r531": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column E))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r532": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column F))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r533": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column G))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r534": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column H))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r535": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Column I))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r536": {
"role": "http://www.xbrl.org/2003/role/disclosureRef",
"Topic": "970",
"SubTopic": "360",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-28(Footnote 2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
},
"r537": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(e)",
"SubTopic": "10",
"Topic": "235",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
},
"r538": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "13H",
"Subparagraph": "(a)",
"SubTopic": "40",
"Topic": "944",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
},
"r539": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "13H",
"Subparagraph": "(b)",
"SubTopic": "40",
"Topic": "944",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
},
"r540": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "210",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "16",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16"
},
"r541": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "210",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "21",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21"
},
"r542": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "210",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "22",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
},
"r543": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
},
"r544": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
},
"r545": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "52",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
},
"r546": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "30",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
},
"r547": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "31",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
},
"r548": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "280",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "47",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
},
"r549": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "69B",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
},
"r550": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "470",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "69C",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
},
"r551": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "606",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "91",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
},
"r552": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "606",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "91",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
},
"r553": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r554": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r555": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "17",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
},
"r556": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "18",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18"
},
"r557": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "715",
"SubTopic": "80",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
},
"r558": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r559": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "805",
"SubTopic": "50",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
},
"r560": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "852",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "10",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
},
"r561": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "944",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
},
"r562": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
},
"r563": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
},
"r564": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
},
"r565": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "310",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"Subparagraph": "(d)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
},
"r566": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
},
"r567": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "2",
"Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
},
"r568": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
},
"r569": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "320",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "6",
"Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
},
"r570": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "10",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
},
"r571": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "12",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
},
"r572": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "13",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-13"
},
"r573": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "14",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-14"
},
"r574": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "15",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-15"
},
"r575": {
"role": "http://www.xbrl.org/2003/role/exampleRef",
"Topic": "946",
"SubTopic": "830",
"Name": "Accounting Standards Codification",
"Section": "55",
"Paragraph": "16",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-16"
},
"r576": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12"
},
"r577": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b"
},
"r578": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-2"
},
"r579": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "b-23"
},
"r580": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "d1-1"
},
"r581": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12",
"Subsection": "g"
},
"r582": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "12, 13, 15d"
},
"r583": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "13e",
"Subsection": "4c"
},
"r584": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "14d",
"Subsection": "2b"
},
"r585": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Number": "240",
"Section": "15",
"Subsection": "d"
},
"r586": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Exchange Act",
"Section": "14a",
"Number": "240",
"Subsection": "12"
},
"r587": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-K",
"Number": "249",
"Section": "310"
},
"r588": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 10-Q",
"Number": "240",
"Section": "308",
"Subsection": "a"
},
"r589": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Number": "249",
"Section": "220",
"Subsection": "f"
},
"r590": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "16",
"Subsection": "J",
"Paragraph": "a"
},
"r591": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1"
},
"r592": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i"
},
"r593": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "A"
},
"r594": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "B"
},
"r595": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "C"
},
"r596": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "D"
},
"r597": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "E"
},
"r598": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "ii"
},
"r599": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "iii"
},
"r600": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Section": "6",
"Subsection": "F",
"Paragraph": "2"
},
"r601": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 20-F",
"Subsection": "F",
"Paragraph": "1",
"Subparagraph": "ii",
"Section": "6"
},
"r602": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Number": "249",
"Section": "240",
"Subsection": "f"
},
"r603": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a"
},
"r604": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1"
},
"r605": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "i"
},
"r606": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "ii"
},
"r607": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iii"
},
"r608": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iv"
},
"r609": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "v"
},
"r610": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "2"
},
"r611": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "a",
"Subparagraph": "3"
},
"r612": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form 40-F",
"Section": "19",
"Paragraph": "b"
},
"r613": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a"
},
"r614": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1"
},
"r615": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "i"
},
"r616": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "ii"
},
"r617": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iii"
},
"r618": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "iv"
},
"r619": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "1",
"Sentence": "v"
},
"r620": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "2"
},
"r621": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "a",
"Subparagraph": "3"
},
"r622": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Form N-CSR",
"Section": "18",
"Paragraph": "b"
},
"r623": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Forms 10-K, 10-Q, 20-F",
"Number": "240",
"Section": "13",
"Subsection": "a-1"
},
"r624": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v"
},
"r625": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "1"
},
"r626": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "ii"
},
"r627": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iii"
},
"r628": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "iv"
},
"r629": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "2",
"Subparagraph": "vi"
},
"r630": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "3"
},
"r631": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "4"
},
"r632": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "i"
},
"r633": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "ii"
},
"r634": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "iii"
},
"r635": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "5",
"Subparagraph": "iv"
},
"r636": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "6"
},
"r637": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "v",
"Paragraph": "6",
"Subparagraph": "i"
},
"r638": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w"
},
"r639": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1"
},
"r640": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i"
},
"r641": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "A"
},
"r642": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "B"
},
"r643": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "C"
},
"r644": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "D"
},
"r645": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "i",
"Sentence": "E"
},
"r646": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "ii"
},
"r647": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "1",
"Subparagraph": "iii"
},
"r648": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "w",
"Paragraph": "2"
},
"r649": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "1"
},
"r650": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2"
},
"r651": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "A"
},
"r652": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "C"
},
"r653": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "D"
},
"r654": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "E"
},
"r655": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "402",
"Subsection": "x",
"Paragraph": "2",
"Subparagraph": "ii",
"Sentence": "F"
},
"r656": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a"
},
"r657": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "1"
},
"r658": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "A"
},
"r659": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "B"
},
"r660": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "C"
},
"r661": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "a",
"Paragraph": "2",
"Subparagraph": "D"
},
"r662": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-K",
"Number": "229",
"Section": "408",
"Subsection": "b",
"Paragraph": "1"
},
"r663": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Regulation S-T",
"Number": "232",
"Section": "405"
},
"r664": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "405"
},
"r665": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "230",
"Section": "425"
},
"r666": {
"role": "http://www.xbrl.org/2003/role/presentationRef",
"Publisher": "SEC",
"Name": "Securities Act",
"Number": "7A",
"Section": "B",
"Subsection": "2"
},
"r667": {
"role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
"Topic": "272",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
},
"r668": {
"role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
"Topic": "830",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-3"
},
"r669": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(B)",
"SubTopic": "20",
"Topic": "715",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r670": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4H",
"SubTopic": "40",
"Topic": "944",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
},
"r671": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "9",
"Subparagraph": "(a)",
"SubTopic": "10",
"Topic": "740",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
},
"r672": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r673": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(17))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r674": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(27)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r675": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(28))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r676": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r677": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "210",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.5-02(9))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
},
"r678": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "4",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
},
"r679": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
},
"r680": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "220",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
},
"r681": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
},
"r682": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "230",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "28",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
},
"r683": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(d))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r684": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(g)(1)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r685": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "235",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
},
"r686": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "23",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
},
"r687": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "24",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
},
"r688": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "250",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "5",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
},
"r689": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "260",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "55",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
},
"r690": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "323",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
},
"r691": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "340",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
},
"r692": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "450",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "9",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
},
"r693": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "450",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 5.Y.Q2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
},
"r694": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(ii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r695": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "470",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1A",
"Subparagraph": "(SX 210.13-01(a)(4)(iii))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
},
"r696": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "505",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
},
"r697": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "606",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "5",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
},
"r698": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r699": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r700": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(10)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r701": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r702": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r703": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r704": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(5)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r705": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(6)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r706": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r707": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(8)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r708": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(a)(9)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r709": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r710": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r711": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r712": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r713": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r714": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(5)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r715": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(6)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r716": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r717": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(b)(8)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r718": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r719": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r720": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(ii)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r721": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r722": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r723": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(A)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r724": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(02)(C)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r725": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(d)(iv)(03)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r726": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(e)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r727": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r728": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(g)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r729": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r730": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r731": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r732": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r733": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r734": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(5)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r735": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(6)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r736": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(h)(7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r737": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(i)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r738": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(j)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r739": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(k)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r740": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(k)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r741": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(k)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r742": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(k)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r743": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(n)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r744": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Subparagraph": "(q)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
},
"r745": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
},
"r746": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
},
"r747": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
},
"r748": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r749": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(1)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r750": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r751": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r752": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(4)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r753": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(5)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r754": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(6)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r755": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(a)(7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r756": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6"
},
"r757": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "715",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "8",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8"
},
"r758": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "718",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(c)(1)(iv)(01)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
},
"r759": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "730",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
},
"r760": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "12",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
},
"r761": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "15",
"Subparagraph": "(c)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
},
"r762": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
},
"r763": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "6",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
},
"r764": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "740",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SAB Topic 6.I.7)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
},
"r765": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "805",
"SubTopic": "50",
"Name": "Accounting Standards Codification",
"Section": "15",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
},
"r766": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "805",
"SubTopic": "50",
"Name": "Accounting Standards Codification",
"Section": "25",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
},
"r767": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "805",
"SubTopic": "50",
"Name": "Accounting Standards Codification",
"Section": "30",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
},
"r768": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "805",
"SubTopic": "50",
"Name": "Accounting Standards Codification",
"Section": "30",
"Paragraph": "2",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
},
"r769": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "815",
"SubTopic": "40",
"Name": "Accounting Standards Codification",
"Section": "65",
"Paragraph": "1",
"Subparagraph": "(e)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
},
"r770": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "820",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2",
"Subparagraph": "(bbb)(2)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
},
"r771": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "825",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "28",
"Subparagraph": "(f)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
},
"r772": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "842",
"SubTopic": "20",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Subparagraph": "(a)(3)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
},
"r773": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "850",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "3",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
},
"r774": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "852",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
},
"r775": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "852",
"SubTopic": "10",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "7",
"Subparagraph": "(b)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
},
"r776": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "912",
"SubTopic": "730",
"Name": "Accounting Standards Codification",
"Section": "25",
"Paragraph": "1",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
},
"r777": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "944",
"SubTopic": "30",
"Name": "Accounting Standards Codification",
"Section": "50",
"Paragraph": "2B",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
},
"r778": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "946",
"SubTopic": "205",
"Name": "Accounting Standards Codification",
"Section": "45",
"Paragraph": "4",
"Subparagraph": "(a)",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
},
"r779": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "946",
"SubTopic": "210",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "1",
"Subparagraph": "(SX 210.6-04(18))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
},
"r780": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(4)(b))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
},
"r781": {
"role": "http://www.xbrl.org/2009/role/commonPracticeRef",
"Topic": "946",
"SubTopic": "220",
"Name": "Accounting Standards Codification",
"Section": "S99",
"Paragraph": "3",
"Subparagraph": "(SX 210.6-09(7))",
"Publisher": "FASB",
"URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
}
}
} |
